CV

CURRICULUM VITAE
HENRY BUCHWALD, MD, PhD
Updated: February 22, 2023
1
PROFESSIONAL ADDRESS
University of Minnesota
Department of Surgery
420 Delaware St SE, MMC 290
Minneapolis, MN 55455
Telephone Number: 612-600-5993
IDENTIFYING INFORMATION
Education
Degree Institution Date Degree Granted
B.A. Columbia College,
Columbia University,
New York City, NY
1954
M.D. College of Physicians & Surgeons,
Columbia University,
New York City, NY
1957
M.S.
(Biochemistry)
University of Minnesota,
Minneapolis, MN
1966
Ph.D.
(Surgery)
Minneapolis, MN
1966
Internship
(Surgery)
Columbia Presbyterian Medical Center,
New York City, NY
1957 - 1958
Residency
(Surgery)
Minneapolis, MN
1960 - 1966
Certifications, Licenses
American Board of Surgery (#014589) 1967 - Present
Medical License Number 15522, Minnesota 1960 -
Present
Medical License, New York 1958
DEA Registration Number AB4431273
Academic Appointments
Owen H. and Sarah Davidson Wangensteen Chair in Experimental 2001 - 2004
Surgery
Professor of Biomedical Engineering 1977 - Present
Professor 1977 - Present
Associate Professor 1970 - 1977
Assistant Professor 1967 - 1970
Instructor 1966 - 1967
Clinical/Hospital Appointments
Staff Physician, University of Minnesota Medical Center, 1997 - 2014
Fairview, Minneapolis, MN
Staff Physician, University of Minnesota Hospital, 1996 - 1997
Minneapolis, MN

CURRICULUM VITAE
2
Membership and Offices in Professional Organizations
Medical Alley Health Care Commission, Technology Task Force, 1992
Moderator, American College of Surgeons Surgical Research 1992
& Education Committee Symposium
ASA representative to Council of Academic Societies/Assoc of 1992 - 1995
Am Medical Colleges
Treasurer, Central Surgical Association 1990 - 1993
(Chairman) 1984 – 1985
Program Committee, Society for Clinical Trials 1984 - 1992
Program Committee, American Society for Artificial Internal Organs 1983 - 1986
American Obesity Association
Program Committee, Central Surgical Association 1982 - 1985
International Study Group on Diabetes Treatment with Implantable
Insulin Delivery Devices
International Atherosclerosis Society
American Society for Artificial Internal Organs
American Association for the Advancement of Science
Saint Paul Surgical Society, Honorary
American Association for the History of Medicine
Minnesota Heart Association
Minnesota Medical Association and Hennepin Medical Society
Minnesota Surgical Association
Minneapolis Surgical Society
Fellow, American College of Nutrition
Fellow, International College of Surgeons
Fellow, American Society for Bariatric Surgery
Fellow, Society for Clinical Trials
Fellow, Society for Surgery of the Alimentary Tract
Fellow, American College of Cardiology
Fellow, Cardiovascular Surgery Council of the American Heart Association
Fellow, Epidemiology Council of the American Heart Association
Fellow, Association for Academic Surgery
Fellow, Central Surgical Association
Fellow, Society of University Surgeons,
Fellow, American College of Surgeons
Fellow, American Surgical Association
Fellow (Hon), Royal College of Surgeons, England
Other Professional Employment
Military Service 1958 - 1960
Captain, SAC, USAF (Flight Surgeon)
HONORS AND AWARDS FOR RESEARCH WORK, TEACHING, PUBLIC
ENGAGEMENT, AND SERVICE
University of Minnesota
Plaque on University of Minnesota Medical School’s 11/07/2016
Wall of Scholarship, recognizing highly cited work of scholarship

CURRICULUM VITAE
3
for paper (Buchwald H, et al. Weight and type 2 diabetes after
bariatric surgery: Systematic review and meta-analysis. Am J
Med 2009; 122(3):248-56)
Elected to membership in the University of Minnesota Academic 09/01/2015
Health Center’s Academy for Excellence in Health Research
Plaque on University of Minnesota Medical School’s 10/23/2014
Wall of Scholarship, recognizing highly cited work of scholarship
for paper (Buchwald et al. Bariatric Surgery: A systematic review
and meta-analysis. JAMA 2004; 292:1724-37)
Inaugural Class of Researchers for the Academy of Medical Device 04/12/2012
Innovators, University of Minnesota
Honored with a plaque on the University of Minnesota’s 2006
Wall of Discovery on the Scholars Walk
University of Minnesota, Department of Surgery’s Wangensteen 2002
Award for Excellence in Teaching
Harold S. Diehl Award, University of Minnesota 2002
Medical Alumni Society
Annual Clinical Scholar Award, University of Minnesota 1991
Medical School
External Sources
Gold Medal for Lifetime Achievement in Research, 2020
Vagelos College of Physicians and Surgeons, Columbia University
Jacobson Innovation Award, American College of Surgeons 2019
Honorary Member Kazakhstan College of Surgeons 2018
Honorary President Kazakhstan International Congress of Bariatric 07/04/2018
and Metabolic Surgery
Induction as Honorary Member of the Royal College of Surgeons, 03/12/2014
London, England
Honored by the New York Stock Exchange at the Ceremonial Ringing 01/31/2013
of the Closing Bell for initiation of the HOPE (Heart Obesity
Prevention Education) program for retired NFL football players, in
association with the NFL Players Association, the Living Heart
Foundation, and Covidien Inc.
Honorary Member, Spanish Obesity Surgery Society (SECO) 04/2012
Honorary Member, Brazilian Society for Surgery of Obesity and 2010
Metabolic Diseases
Honorary Member, Japan Society for Treatment of Obesity 07/10/2009
Honorary Member, Austrian Society for Surgery of Obesity and 2009
Metabolic Disease
Best Author Award for 1994, Obesity Surgery 1994
Governor's Board of Invention 1993 - 1994
Tribute to Dr. Henry Buchwald, Senate Congressional Record 1991
The Meritorious Service Award in Research and Development,
Medical Alley Association 03/29/1990
Outstanding Achievement Award, Minnesota Medical Alley 1989 - 1990
Inventor of the Year Award and induction into the Minnesota 1988
Inventors Hall of Fame
Distinguished Service Award, Association for Academic Surgery 1976
Samuel D. Gross Prize, Philadelphia Academy of Surgery 1967

CURRICULUM VITAE
4
“Cholesterol Metabolism and Atherosclerosis as Influenced by
Partial Small Bowel Intestinal Exclusion”
Phi Lambda Upsilon Honorary Chemistry Fraternity 1966
First Prize, Res. Forum, American College of Chest Physicians 1966
American Heart Association Established Investigatorship 1964 - 1969
Helen Hay Whitney Fellowship Award 1962 - 1964
First Clinical Research Award, Minnesota Surgical Society 1965
Shering Award 1957
Essay Prize, American College of Chest Physicians 1957
Alpha Omega Alpha 1956
Research Fellowship, Foundation for Allergic Disease 1956
Valedictorian, summa cum laude, first in class, Columbia College 1954
Albert Ascher Green Scholastic Award 1954
RESEARCH AND SCHOLARSHIP
Grants and Contracts
Principal Investigator or Program Director – Past
Covidien Grant
Institute for Basic and Applied Research in Surgery (IBARS) Grant 2018
Ethicon Endo-Surgery, Inc., “The effect of mucosal resection and gastric
suture line durability, phase 2,”
2006-2007 $25,889
Ethicon Endo-Surgery, Inc., “Serosa to serosa suture line durability,” 2006 $66,598
University of Minnesota, Department of Surgery, Laboratory funding from the
Owen H. and Sarah Davidson Wangensteen Chair in Experimental Surgery
2001-2004
Transneuronix, Inc., “A clinical study to evaluate the safety and efficacy of the
Transcend Implantable Gastric Stimulation System for Weight Loss”
2001-2002 $45,761
Murphy Medical Research Fund, “O2 Diffusion as a Function of Cholesterol
Concentration”
1996-2001
NIH, National Heart, Lung, and Blood Institute, “POSCH: Long-Term 1993-1997
Mortality and Morbidity,” Merck Corporation, gift in support of the POSCH
trial
1992-1994
FDA, “New Peritoneovenous Shunt for the Treatment of Ascites” 1989-1994
Sandoz Corporation, “The Effects of Sandoz Diet Formulas on Atherosclerosis
in Diet-Induced Hypercholesterolemic Rabbits,”
1991 $95,512
Strato Medical Corporation, “In-Vivo Evaluation of the Minnesota
Peritoneovenous Shunt,”
1991
Strato Medical Corporation, “In-Vivo Evaluation of the Bidirectional
Antireflux Catheter”
1990-1991
The Upjohn Company (Study to Assess the Effect of Pioglitazone on Insulin
Sensitivity)
1989
Medtronic, Inc., “Development of Insulin Delivery by the Medtronic
SynchroMed™ Infusion Pump”
1988-1990
The Upjohn Company, “Glucregulation in Type II Diabetic Patients with the
Combination of the Minnesota Implantable Insulin Infusion
1987-1989

CURRICULUM VITAE
5
Pump and the Second Generation SulfonylureA, Glyburide “MICRONASE”,
National Institute of Arthritis, Metabolism, and Digestive Diseases,
“Adjuvants to Partial Ileal Bypass for Lipid Lowering”
1984-1987
National Institute of Arthritis, Metabolism, and Digestive Diseases, “Insulin
Infusion in Type II Diabetics by Implanted Pump”
1982-1984
National Institute of Arthritis, Metabolism, and Digestive Diseases, “An Open
Loop' Insulin Delivery Device for the Control of Glycemia”
1978-1982
National Institute of Arthritis, Metabolism, and Digestive Diseases, “Method
of Treatment and Nephropathy in Diabetic Dogs”
1978-1982
Eli Lilly Company, “Glucagon Research Program” 1978-1979
Minnesota Medical Foundation, “Surgical Control of the Hyperlipidemias” 1978-1979
General Mills Foundation, support for “Surgical Control of the
Hyperlipidemias”
1979
National Institute of Arthritis, Metabolism, and Digestive Diseases, “Totally
Implantable Artificial Beta Cell"
1977-1978
National Cancer Institute, “Cancer Chemotherapy with a Totally Implantable
Pump”
1977-1978
General Mills Corporation, “Cord Blood Study” 1976
NIH National Institute of General Medical Sciences, “Device for Continuous
Infusion Drug Screening”
1976-1978
National Heart & Lung Institute, “Xylocaine Infusion by an Implantable
Infusion Pump”, National Institutes of Health, NHLBI
1973-1974
“Program on the Surgical Control of the Hyperlipidemias (POSCH),” a multi-
institutional intervention trial on surgical management of hyperlipidemia,
[NCT00000490]
1973-1997
National Heart and Lung Institute, “Cholesterol and Bile Acid Metabolism” 1972-1977
Upjohn Company, “Development of an Implantable Infusion Pump” 1971-1974
Minnesota Heart Association, “Cholesterol and Bile Acid Metabolism” 1971-1973
Minnesota Medical Foundation, “Relationship of Hyperlipidemia to
Atherosclerosis”
1971-1972
Metal Bellows Corporation, “Development of an Implantable Infusion Pump” 1970-1985
Minnesota Medical Foundation, “Management of the Hyperlipidemias” 1970-1972
Legislative Grant, State of Minnesoota, “Management of the Hyperlipidemias” 1969-1982
University of Minnesota, Graduate School Grant, University of Minnesota,
“Cholesterol Metabolism”
1969-1970
NIH, National Heart & Lung Institute, “Cholesterol Metabolism and Partial
Ileal Bypass”
1967-1982
University of Minnesota, Graduate School Grant, “Cholesterol Levels” 1966-1967
University of Minnesota, Graduate School, “Evaluation of Ileal Bypass
Operation”
1966
American Heart Association, “Cholesterol Metabolism” 1964-1971
American Society for Allergic Disease, “Histamine Quantification” 1956-1957

CURRICULUM VITAE
6
Co-Investigator – Past
United States Army Medical Research and Materiel Command, Breast Cancer Research
Program, “A Novel Approach to Increase Breast Cancer Chemosensitivity: Disruption of the
Anti-Apoptotic Function of Translation Factor eIF4E,” (Dr. Vitaly Polunovsky, Principal
Investigator)
1999
Publications
Syndicated Column - General Surgery News every other month 2015 – Present
1. Bowel Obstruction Revisited February 2023
2. Masking Deadly Breath December, 2022
3. Data- Small, Big, True, False October, 2022
4. The Corruption of Care August, 2022
5. Curing Diabetes Mellitus June, 2022
6. Grandfather Did It April, 2022
7. Decisions Forced on Us by COVID-19 February, 2022
8. Words, Words, Words December, 2021
9. Vaccination: Penicillin for Pandemics October, 2021
10. Inflammation Everywhere August, 2021
11. Ants To Robotics: Ten Tools of Surgery June, 2021
12. Traumatic Brain Injury April, 2021
13. What Will Follow the Virtual World of COVID-19 For Medical Practitioners? February, 2021
14. Metabolic Surgery in The Era of COVID-19 December, 2020
15. The Virtual ACS Congress 2020 and Beyond October, 2020
16. A Tribute to Health Care’s First Responders August, 2020
17. Pandemics and Epidemics: What’s Been Plaguing Us June, 2020
18. Principles and Commitments April, 2020
19. Recidivism is Not Failure February, 2020
20. Oxygen Transport: Life Determinant December, 2019
21. The Doctor Patient Relationship: Defined by Era October, 2019
22. The Doctor Patient Relationship: Defined by Language August, 2019
23. The Statins: Beyond Cholesterol June, 2019
24. Courtesy: Professional, Patient, Personal April, 2019
25. Open Thought Research February, 2019
26. Why Only in Kazakhstan December, 2018
27. The American College of Surgeons Metabolic Surgery Symposium October, 2018
28. Doing the Right Thing August, 2018
29. A Short History on Obesity June, 2018
30. Why Grand Rounds? March, 2018
31. Hyperlipidemia: Fact and Fiction February, 2018
32. Toilers in the Vineyard and Leadership from Behind the Curtain December 2017
33. Joy in the Process October, 2017
34. Metabolic Surgery: Just in Time August, 2017
35. Life Fast, Die Young… Ageism and Age Discrimination May, 2017
36. Treating Metrics Rather Than Patients March, 2017
37. The Chair: The Chief January, 2017
38. Burnout in Surgery November, 2016
39. Diabetes and the Surgeon October, 2016
40. Conflict of Interest: Time for Reevaltuation August, 2016
41. 33 Days in a Hospitalist Hospital May, 2016

CURRICULUM VITAE
7
42. Why an Open Abdominal Surgery Specialist Fellowship February, 2016
43. What Makes a Successful and Happy Surgeon? December, 2015
44. Reflections on a Surgeon’s Autonomy October, 2015
45. Where Do We Come From? What Are We? Where Are We Going? August, 2015
Peer-Reviewed Publications
1. Buchwald H. Scott Shikora, MD, FACS. Obes Surg. 2020:30:795–796.
2. Buchwald H. Metabolic (Not Mechanical) Surgery for Metabolic Diseases. J Am Coll Surg.
2020;230(6):1054‐1055. doi:10.1016/j.jamcollsurg.2019.12.045.
3. Buchwald H, Buchwald JN, Pories WJ, Hoyt DB. Executive Summary: Collected Papers of the
American College of Surgeons Metabolic Surgery Symposium. Obes Surg. 2020;30(5):1961‐1970.
doi:10.1007/s11695-020-04451-1.
4. Buchwald H, Pories W. Foreword and Dedication, Collected papers of the ACS Metabolic Surgery
Symposium, Part 1. Am Coll Surg Bulletin. 2018:103:47-50.
5. Buchwald H, Fobi M, Herron D, Brethauer S. Definition and history of metabolic surgery. Collected
papers of the ACS Metabolic Surgery Symposium, Part 1. Am Coll Surg Bulletin. 2019:104:43-52.
6. Buchwald, H, & Buchwald, J. Metabolic (Bariatric and Non-bariatric) Surgery for Type 2 Diabetes:
A Personal Perspective Review. Diabetes Care 2019: 42(2): 331-340. doi:10.2337/dc17-2654.
7. Buchwald, H, Roberts, A, Thornton, J, & Louchiey, C. Obesity in the fifth quarter: A malignancy in
former NFL players significance and potential Surg Obes Relat Dis. 2018:14(8): 1202-1204.
doi:10.1016/j.soard.2018.05.021.
8. Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, Buchwald H, Scopinaro N.
IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures. Obes Surg. 2018
Dec;28(12):3783-3794. doi: 10.1007/s11695-018-3450-2.
9. Buchwald H. Impact of Bariatric Surgery on Life Expectanct in Severely Obese Patients with
Diabetes. Annals of Surgery 2017: 266(6):e57. doi: 10.1097/SLA.0000000000001356.
10. Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, Scopinaro N. Erratum to:
Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014. Obes Surg 2017:27:
2290-2. https://doi.org/10.1007/s11695-017-2773-8.
11. Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, Scopinaro N. Bariatric
Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014. Obes Surg 2017:27(9):2279-
89.
12. Buchwald H, Oien D. Revision Roux-en-Y Gastric Bypass to Biliopancreatic Long-Limb Gastric
Bypass for Inadequate Weight Response: Case Series and Analysis. Obes Surg. 2017 Sep;27(9):2293-
2302. doi: 10.1007/s11695-017-2658-x.
13. De Luca M, Angrisani L, Himpens J, Busetto L, Scopinaro N, Weiner R, Sartori A, Stier C,
Lakdawala M, Bhasker AG, Buchwald H, Dixon J, Chiappetta S, Kolberg HC, Frühbeck G, Sarwer
DB, Suter M, Soricelli E, Blüher M, Vilallonga R, Sharma A, Shikora S. Indications for surgery for
obesity and weight-related diseases: Position Statements from the International Federation for the
Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg 2016:26(8):1659-1696.

CURRICULUM VITAE
8
14. Buchwald H, Thomas AJ, Williams SE. Connett JE. Arteriographic predictability of all-cause and
myocardial infarction deaths in the Program on the Surgical Control of the Hyperlipidemias (POSCH).
Submitted, 2016.
15. Buchwald H, Oien DM, Schieber DJ, Bantle JP, Connett JE. Partial ileal bypass affords protection
from onset of type 2 diabetes. Surg Obes Relat Dis. 2016 [Epub ahead of print]
doi: 10.1016/j.soard.2016.01.025.
16. Buchwald H. Comment on: Bariatric surgery in 1119 patients with preoperative body mass index
>35kg/m2: results at 1 year. Surg Obes Relat Dis 2015;11(5):1132-1133.
17. Scibora LM, Buchwald H, Petit MA, Hughes J, Ikramuddin S. Bone strength is preserved following
bariatric surgery. Obes Surg 2015;25:263-270. doi: 10.1007/s11695-014-1341-8
18. Michalik M, Bobowicz M, Buchwald H. A numerical scale to assess the outcomes of
metabolic/bariatric surgery (NOMS). Videosurg J, 2015; 10(3): DOI: 10.5114/wiitm.2015.54085.
19. Buchwald H. Comment on: Bariatric surgery in 1160 patients with preoperative body mass index <35
kg/m2: results at 1 year. Surg Obes Relat Dis 2015; online prior to print.
http://dx.doi.org/10.1016/j.soard.2014.12.001.
20. Buchwald H. One surgeon’s principles. Amer Coll Surg Bulletin 2015;100(5):54-56.
21. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery
worldwide 2013. Obes Surg 2015; 25:1822-1832.
22. Buchwald H. Revisional metabolic/bariatric surgery: a moral obligation. Obes Surg 2015;25(3):547-
549. Doi: 10.1007/s11695-014-1458-9.
23. Feeman WE Jr, Williams SE, Buchwald H. The Program on the Surgical Control of the
Hyperlipidemias (POSCH) and the lipid regulatory hypothesis. EMJ Cardiol. 2015; 3(1):67-76.
24. Barnes M, Buchwald H, Jessurun J, Menk J, Ikramuddin S, Stewart C. The relationship between a
diagnosis of obstructive sleep apnea and the histologic stage of nonalcoholic fatty liver disease in obesity.
J Hepatol, in press, 2014.
25. Buchwald H, O’Dea TJ. A novel method for measuring the cross-sectional area of and flow rate
through the upper gastrointestinal system. A feasibility study. J Clin Eng 2014; 39(4):184-189.
26. Buchwald H. Revisional metabolic/bariatric surgery: a moral obligation. Surg Obes Relat Dis, online
prior to print, 16 Sept 2014. Doi: 10.106/j.soard.2014.09.006.
27. Scibora LM, Buchwald H, Petit MA, Hughes J, Ikramuddin S. Bone strength is preserved following
bariatric surgery. Obes Surg, online prior to print, 01 July 2014. doi: 10.1007/s11695-014-1341-8
28. Buchwald H, O’Dea TJ. A novel method for measuring the cross-sectional area of and flow rate through
the upper gastrointestinal system. A feasibility study. J Clin Eng 2014; 39(4):184-189.
29. Buchwald H. The evolution of metabolic/bariatric surgery. Obes Surg, 2014; 24:1126-1135. doi:
10.1007/s11695-014-1354-3.
30. Buchwald H, Buchwald JN, McGlennon TW. Systematic review and meta-analysis of medium-term
outcomes after banded Roux-en-Y gastric bypass. Obes Surg, 2014; 24:1536-1551.
doi: 10.1007/s11695-014-1311-1.

CURRICULUM VITAE
9
31. Buchwald H, Dorman RB, Rasmus NF, Michalek VN, Landvik NM, Ikramuddin S. Effects on GLP-1,
PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: Implications for ileal
transposition. Surg Obes Relat Dis, 2014; 10:780-786. doi.org/10.1016/j.soard.2014.01.032.
32. Buchwald H, Roberts AJ. The HOPE (Heart, Obesity, Prevention, Education) Program for former NFL
players. Surg Obes Relat Dis, 2014; 10(4):573-575. doi.org/10.1016/j.soard.2014.02.030.
33. Buchwald H, Menchaca HJ, Michalek VN, Bertin Suguitani NT. Ileal effect on blood glucose, HgbA1c
and GLP-1 in Gato-Kakizaki rats. Obes Surg, 2014; 24:1954-1960.
doi: 10.1007/s11695-014-1307-x.
34. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg, 2013, 23(4):427-436.
doi: 10.1007/s11695-012-0864-0.
35. Oura M, Menchaca HJ, Erdman AG, Buchwald H. Surgical access system for frugal bariatric surgery.
ASME J Med Devices 2013; 7(2):020947 (June 21 2013); doi: 10.1115/1.4024792.
36. Al-Nowaylati AR, al-Haddad BJS, Dorman RB, Lake JR, Chinnakolta S, Sampson BK, Ikramuddin S,
Buchwald H, Leslie DB. Gastric bypass post liver transplant. Liver Transpl 2013, 19(12):1324-9. doi:
10.1002/lt.23734. Epub 2013 Oct 21.
37. Dorman RB, Serrot FJ, Miller CJ, Slusarek B, Sampson B, Buchwald H, Leslie DB, Bantle JP,
Ikramuddin S. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the
morbidly obese patient. Ann Surg 2012; 255(2):287-293.
38. Leslie DB, Dorman RB, Serrot F, Swan TW, Buchwald H, Kellog TA, Torres-Villalobos G, Slusarek
BM, Sampson B, Bantle JP, Ikramuddin S. Efficacy of the Roux-en-Y gastric bypass compared to
medically-managed controls in meeting the American Diabetes Association composite end point
goals for management of type 2 diabetes mellitus. Obes Surg 2012; 22(3):367-374.
39. Leslie DB, Dorman RB, Anderson J, Serrot FJ, Kellogg TA, Buchwald H, Sampson BK, Slusarek
BM, Ikramuddin S. Routine upper gastrointestinal imaging is superior to clinical signs for detecting
gastrojejunal leak after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg 2012; 214(2):208-
213.
40. Scibora LM, Ikramuddin S, Buchwald H, Petit MA. Examining the link between bariatric surgery, bone
loss, and osteoporosis: a review of bone density studies. Obes Surg 2012; 22:654-667.
41. Dorman RB, Miller CJ, Leslie DB, Serrot JN, Slusarek B, Buchwald H, Connett JE, Ikramuddin S.
Risk for hospital readmission following bariatric surgery. PloS ONE 2012; 7(3):e32506.
42. Dorman RB, Rasmus NF, al-Haddad BJS, Serrot FJ, Slusarek BM, Sampson BK, Buchwald H, Leslie,
BD, Ikramuddin S. Benefits and complications of the duodenal switch/biliopancreatic diversion
compared to the Roux-en-Y gastric bypass. Surgery 2012; 152(4):758-767.
43. Buchwald H. Interview: Metabolic/bariatric surgery. Clin Pract 2012; 9(5):503-507.
44. Torres-Villalobos G, Leslie DB, Hunter D, Buchwald H, Martin-del-Campo L, Ikramuddin S.
Preliminary report: search for a transgastric approach for managing gastrogastric fistulas. World J
Surg 2011; 35(2):372-376.
45. Menchaca HJ, Harris JL, Thompson SE, Mootoo M, Michalek VN, Buchwald H. Gastric plication:
a preclinical study of the durability of serosa-to-serosa apposition. Surg Obes Relat Dis, 2011; 7:8-
14.

CURRICULUM VITAE
10
46. Ikramuddin S, Buchwald H. How bariatric and metabolic operations control metabolic syndrome.
Brit J Surg 2011; 98:1339-1341.
47. Serrot FJ, Leslie D, Dorman RB, Anderson J, Sick B, Slusarek B, Buchwald H, Ikramuddin S.
Comparative effectiveness of bariatric surgery and non-surgical therapy in adults with type 2 diabetes
mellitus (T2DM) and class I obesity. Surgery 2011; 150(4):684-691.
48. Buchwald H, Ikramuddin S, Dorman RB, Schone JL, Dixon JB. Management of the
metabolic/bariatric surgery patient. Am J Med 2011; 124:1099-1105.
49. Buchwald H, Scopinaro N. With thanks and gratitude. Obes Surg 2011; 21:1815-1916.
50. Buchwald H, Menchaca HJ, Michalek VN, Suguitani NT, Singh H, George P, Belani KG. Micro-
orifice metabolic/bariatric surgery under IV sedation/local anesthesia. Obes Surg 2010; 20:500-505.
51. Buchwald H. Metabolic Surgery: a brief history and perspective (editorial). Surg Obes Relat Dis
2010; 6(2):221-222.
52. Buchwald H, Rudser KD, Williams SE, Michalek VN, Vagasky J, Connett JE. Overall mortality,
incremental life expectancy, and cause of death at 25-years in the Program on the Surgical Control of
the Hyperlipidemias (POSCH). Ann Surg 2010; 251(6):1034-1040.
53. Buchwald H. Surgery on obese patients. J Am Coll Surg 2010; 210(6):1012-1013.
54. Buchwald H, Scopinaro N. An invitation to our medical colleagues: work with us. Obes Surg 2010;
20(11):1465-1467.
55. Buchwald H, Scopinaro N. Editor’s commentary. Obes Surg 2010; 20(12):1716-1717.
56. Buchwald H, Menchaca HJ, Michalek VN, Rohde TD, O’Dea T, Gorlin J. Oxygen transport rate of
banked red blood cells. VOX Sanguinis 2009; 96:44-48.
57. Whitson BA, D’Cunha J, Hoang CD, Wu B, Ikramuddin S, Buchwald H, Panoskaltsis-Mortari A,
Kratzke RA, Miller JS, Maddaus MA. Minimally invasive versus Roux-en-Y gastric bypass: effect
on immune effector cells. Surg Obes Relat Dis 2009;5:181-193.
58. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories W, Bantle J, Sledge I. Weight and
type 2 diabetes after bariatric surgery: Systematic review and meta-analysis. Am J Med 2009;
122(3):248-256.
59. Buchwald H. The problem of self-determination of professionalism and ethics. Am Coll Surg
Bulletin 2009; 94(4):8-13.
60. Buchwald H, Scopinaro N. Retiring the learning curve [editorial]. Obes Surg 2009; 19:541-542.
61. Buchwald H, Scopinaro N. Editors’ Comment: bariatrics and diabetes meta-analysis. Obes Surg
2009; 19:543.
62. Buchwald H. Meta-analysis confirms bariatric surgery is effective therapy for type 2 diabetes.
Bariatric News, May 2009, 1:9.
63. Kellogg TA, Swan T, Leslie DB, Buchwald H, Ikramuddin S. Patterns of readmission and
reoperation within 90 days following Roux-en-Y gastric bypass. Surg Obes Relat Dis 2009; 5:416-
424.
64. Buchwald H, Oien D. Metabolic/bariatric surgery worldwide 2008. Obes Surg 2009; 19:1605-1611.

CURRICULUM VITAE
11
65. Buchwald H. Chirurgia bariatrica: dale radici ai semi. Chirurgia Bariatrica e Metabolica (editorial),
2009; 15:1-4.
66. Buchwald H. Introduction and current status of bariatric procedures. Surg Obes Relat Dis 2008;
4:S1-S6.
67. Kellogg TA, Leslie DL, Slusarek B, Swan TW, Bantle JP, Buchwald H, Ikramuddin S. Post-gastric
bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet.
Surg Obes Relat Dis 2008; 4:492-499.
68. Crémieux PY, Buchwald H, Shikora S, Ghosh A, Yang E, Buessing M. A study on the economic
impact of bariatric surgery. Am J Manag Care 2008; 14(9):589-596.
69. Buchwald H, Kellogg TA, Leslie DB, Ikramuddin S. Duodenal switch operative mortality and
morbidity are not impacted by BMI. Ann Surg 2008; 248(4):541-548.
70. Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N, Greve JW, Horber F, Mathus-
Vliegen E, Scopinaro N, Steffen R, Tsigos C, Weiner R, Widhalm K. Interdisciplinary European
guidelines on surgery of severe obesity. Obes Facts 2008; 1(1):52-9.
71. Whitson, BA, Leslie, DB, Kellogg, TA, Maddaus, MA, Buchwald H, Billington, CJ, Ikramuddin, S.
Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary
study. J Surg Res 2007; 141:31-39.
72. Kellogg TA, Andrade R, Maddaus M, Slusarek B, Buchwald H, Ikramuddin S. Anatomic findings
and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic
conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis 2007; 3:52-57.
73. Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N, Greve JWM, Horber F, Mathus-
Vliegen E, Scopinaro N, Steffen R, Tsigos C, Weiner R, Widhalm K. Inter-disciplinary European
guidelines on surgery of severe obesity. Int’l J Obes 2007; 31:569-577.
74. Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer, Greve JW, Horber F, Mathus-
Vliegen E, Scopinaro N, Steffen R, Tsigos C, Weiner R, Widhalm K. Interdisciplinary European
guidelines on surgery of severe (morbid) obesity. Obes Surg 2007; 17(2):260-270.
75. Buchwald H. Management of Morbid Obesity: Surgical options. OBG Management 2007; 19
(Suppl):8-14.
76. Bantle JP, Ikramuddin S, Kellogg TA, Buchwald H. Hyperinsulinemic hypoglycemia developing late
after gastric bypass. Obes Surg 2007; 17:592-594.
77. Buchwald H. Is morbid obesity a surgical disease? General Surgery News, Obesity Care Special
Edition 2007:9-15.
78. Avidor Y, Still CD, Brunner M, Buchwald JN, Buchwald H. Primary care and subspecialty
management of morbid obesity: Referral patterns for bariatric surgery. Surg Obes Relat Dis
2007;3:392-407.
79. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a
systematic review and meta-analysis. Surgery 2007; 142(4):621-635.
80. Buchwald H. Surgical intervention for the treatment of morbid obesity and the dyslipidemias.
Future Lipidol 2007; 2(5):513-525.

CURRICULUM VITAE
12
81. Buchwald H, Williams SE. Bariatric surgery training in the United States. Surg Obes Relat Dis
2006; 2(1):52-55.
82. Buchwald H, for the Consensus Conference Panel. Bariatric surgery for morbid obesity: health
implications for patients, health professionals, and third-party payers. J Am Coll Surg 2005; 200:593-
604.
83. Buchwald H. The future of bariatric surgery. Presidential Address, 9th
Congress of the International
Federation for the surgery of Obesity (IFSO), Tokyo, Japan, September 9, 2004. Obes Surg 2005;
15:598-605.
84. DeMaria EJ, Schauer P, Patterson E, Nguyen NT, Jacob BP, Inabnet WB, Buchwald H. The optimal
surgical management of the super-obese patient: the debate. Surg Innov 2005; 12(2):107-121.
85. Barnett SJ, Stanley C, Hanlon M, Acton R, Saltzman DA, Ikramuddin S, Buchwald H. Long-term
follow-up and the role of surgery in adolescents with morbid obesity. Surg Obes Relat Dis 2005;
1(4):394-398.
86. Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg 2004; 14:1157-64.
87. Neumayer L, Giobbie-Hurder A, Jonasson O, Fitzgibbons, Jr R, Dunlop D, Gibbs J, Reda D, Henderson
W, for the Veterans Affairs Cooperative Studies Program 456 Investigators. Open mesh versus
laparoscopic mesh repair of inguinal hernia. N Engl J Med 2004; 350:1819-27. (Buchwald was the
Chair for the Data Monitoring Committee.)
88. Buchwald H. Gastric stimulation: a new paradigm for management of morbid obesity. Obes Surg
2004; 14:S2.
89. Menchaca HJ, Michalek VN, Rohde TD, Hirsch AT, Tuna N, Buchwald H. Improvement of blood
oxygen diffusion capacity and anginal symptoms by cholesterol lowering with Simvastatin. J Applied
Research 2004; 4(3):410-418.
90. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric
Surgery: A systematic review and meta-analysis. JAMA 2004; 292(14):1724-1737.
91. Buchwald H, Boen JR, Williams SE, Nguyen PA, Matts JP. Blood pressure, weight, and cholesterol: a
POSCH report. J Applied Research 2003; 3(2):112-117.
92. Buchwald H. Overview of bariatric surgery. J Am Coll Surg 2002; 194:367-375.
93. Buchwald H, Williams SE, Matts JP, Boen JR. Lipid modulation and liver function tests. J Cardiovasc
Risk 2002; 9(2):83-87.
94. Buchwald H, Buchwald JN. Evolution of operative procedures for the management of morbid obesity
1950-2000. Obes Surg 2002; 12:705-17.
95. Buchwald H, Williams SE, Matts JP, Nguyen PA, Boen JR. Overall mortality in the Program on the
Surgical Control of the Hyperlipidemias. J Am Coll Surg 2002; 195:327-331.
96. Buchwald H. A bariatric surgery algorithm. Obes Surg 2002; 12:733-746.
97. Buchwald H, Ikramuddin S. Introduction to supplement: Laparoscopic Adjustable Gastric Banding in
Bariatric Surgery: An Overview of the LAP-BAND
. Am J Sur 2002; 184 (Suppl):S1-3.
98. Buchwald H, Boen JR, Nguyen PA, Williams SE, Matts JP. Plasma lipids and cardiovascular risk: A
POSCH report. Atherosclerosis 2001; 154:221-227.

CURRICULUM VITAE
13
99. Buchwald H. Risk reduction and the Program on the Surgical Control of the Hyperlipidemias (letter).
Circulation 2001; 104:E47.
100. Nguyen DQ, Buchwald H, Bolman RM III, Goodale RL Jr. Endoscopic laser treatment of obstructing
polypropylene mesh after vertical banded gastroplasty. Gastrointest Endosc 2000; 51:616-7.
101. Buchwald H, Menchaca HJ, Menchaca YM, Michalek VN. Surgically induced weight loss: gastric
bypass vs gastroplasty. Probl in Gen Surg 2000; 17:23-28.
102. Buchwald H, Menchaca HJ, Michalek VN, Rohde TD, Hunninghake DB, O’Dea TJ. Plasma
cholesterol: An influencing factor in red blood cell oxygen release and cellular oxygen availability. J
Am Coll Surg 2000; 191:490-497.
103. O'Dea TJ, Menchaca HJ, Shudy JG, Rohde TD, Michalek VN, Fuller CC, Buchwald H. A novel device
for measuring the effect of cholesterol on the release of oxygen from red blood cell into myocardial
tissue. Biomed Instr Tech 2000; 34:283-92.
104. Buchwald H, Knatterud ME. Morbid obesity: perceptions of character and comorbidities in Falstaff.
Obes Surg 2000; 10:402-8.
105. Buchwald H, O'Dea TJ, Menchaca HJ, Michalek VN, Rohde TD. Effect of plasma cholesterol on red
blood cell oxygen transport. Clin Exper Pharmacol Physiol 2000;27:951-955.
106. Buchwald H. Role of the surgeon in managing hypercholesterolemia. Surgery 1999; 125(5):465-467.
107. Buchwald H. ASBS Presidential Address: Mainstreaming Bariatric Surgery. Obes Surg 1999; 9:462-
470.
108. Buchwald H: Three helpful techniques for facilitating abdominal procedures, in particular for
surgery in the obese. Am J Surg 1998; 175:63-64.
109. Buchwald H, Campos CT, Varco RL, Boen JR, Williams SE, Hansen BJ, Campbell GS, Pearce MB,
Yellin AE, Edmiston WA, Smink RD, Jr, Sawin HS, Jr, for the POSCH Group. Effective lipid
modification by partial ileal bypass reduced long-term coronary heart disease mortality and
morbidity: five-year posttrial follow-up report from the POSCH. Arch Intern Med 1998; 158:1253-
1261.
110. Buchwald H, Hunter DW, Tuna N, Williams SE, Boen JR, Hansen BJ, Titus JL, Campos CT, for the
POSCH Group: Myocardial infarction and percent arteriographic stenosis of culprit lesion.
Atherosclerosis 138:391-401, 1998.
111. Buchwald H. CSA Presidential Address: A clash of cultures: personal autonomy versus corporate
bondage. Surgery 1998; 124:595-603.
112. Menchaca HJ, Michalek VN, Rohde TD, O'Dea TJ, Buchwald H. Decreased blood oxygen diffusion
in hypercholesterolemia. Surgery 1998; 124:692-698.
113. Buchwald H, Rohde TD. International Study Group for Implantable Infusion Devices 1996: The
world’s only implantable infusion pump society. ASAIO J 1997; 43:132-136.
114. Buchwald H, Schone JL: Gastric obesity surgery combined with partial ileal bypass for
hypercholesterolemia. Obes Surg 1997; 7:313-316.
115. Matthews AJ, Menchaca HJ, Michalek VN, Murar J, Vercellotti GM, Buchwald H. Vitamin E
enhances atherosclerosis regression in the diet-induced hypercholesterolemic rabbit model. Surg
Forum 1997; 48:24-26.

CURRICULUM VITAE
14
116. Buchwald H. Surgical procedures and devices should be evaluated in the same way as medical
therapy. Controlled Clin Trials 1997; 18(6):478-487.
117. Matthews AJ, Vercellotti GM, Menchaca HJ, Bloch PHS, Michalek VN, Marker PH, Murar J,
Buchwald H. Iron and atherosclerosis: inhibition by the chelator deferiprone (L1). J Surg Res 1997;
73:35-40.
118. Morris TJ, Palm SL, Furcht LT, Buchwald H. The effect of lovastatin on [3H]-thymidine uptake in
HTC-4 and LLC-L1 tumor cells. J Surg Res 1996; 61:367-372.
119. Buchwald H, Bourdages HR, Campos CT, Nguyen P, Williams SE, Boen JR, for the POSCH Group.
Impact of cholesterol reduction on peripheral arterial disease in the Program on the Surgical Control
of the Hyperlipidemias (POSCH). Surgery 1996; 120:672-679.
120. Buchwald H, Campos CT, Boen JR, Nguyen P, Williams SE, Lau J, Chalmers TC, for the POSCH
Group. Gender-based mortality follow-up from the Program on the Surgical Control of the
Hyperlipidemias (POSCH) and meta-analysis of lipid intervention trials. Ann Surg 1996; 224:486-
500.
121. Matts JP, Buchwald H, Fitch LL, Campos CT, Varco RL, Campbell GS, Pearce MB, Yellin AE,
Smink RD, Sawin HS, Long JM, and the POSCH Group. Subgroup analyses of the major clinical
endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality,
atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial
infarction. J Clin Epidemiol 1995; 48:389-405.
122. Buchwald H, Campos CT, Boen JR, Nguyen PA, Williams SE, and the POSCH Group. Disease-free
intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia:
Report from the Program on the Surgical Control of the Hyperlipidemias (POSCH). J Am Coll
Cardiol 1995; 26:351-7.
123. Buchwald H, Campos CT, for the POSCH Group. Control of risk factors in atherosclerosis: POSCH
report. Ann NY Acad Sci 1995; 748:342-356.
124. Fitch LL, Buchwald H, Matts JP, Johnson JW, Campos CT, Long JM, for the POSCH group. Effect
of aspirin use on death and recurrent myocardial infarction in current and former cigarette smokers.
Am Heart J 1995; 129:656-62.
125. Buchwald H, Campos CT, for the POSCH Group. Program on the Surgical Control of the
Hyperlipidemias: 1994 Report. J Cardiov Pharm 1995; 25(Suppl 4):S3-S10.
126. Morris TJ, Palm SL, Furcht LL, Buchwald H. Effect of lovastatin alone and as an adjuvant
chemotherapeutic agent on hepatoma tissue culture-4 cell growth. Ann Surg Oncol 1995; 2(3):266-
274.
127. Buchwald H. The treatment of hyperlipidemia II. The Formulary Letter, March, 1994.
128. Bourdages H, Goldenberg FJ, Nguyen P, Buchwald H. Improvement in obesity-associated medical
conditions following vertical banded gastroplasty and gastrointestinal bypass. Obes Surg 1994;
4:227-231.
129. Wigness BD, Rohde TD, Dorman FD, Rose R, Buchwald H. A peritoneovenous shunt with an access
port enables non-surgical reversal of intraperitoneal catheter occlusion. ASAIO J 1994; 40:M580-
M583.

CURRICULUM VITAE
15
130. Matthews AJ, Belcher J, Balla J, Murar J, Bourdages H, Menchaca H, Michalek, Vercellotti G,
Buchwald H. Vitamin E inhibits atherosclerosis in the diet induced hypercholesterolemic rabbit
model. Surg Forum 1994; 45:36-38.
131. Bourdages H, Menchaca H, Matthews AJ, Michalek V, Rose R, Shearer JD, Buchwald H.
Administration of intraperitoneal silica enhances regression of atherosclerosis in a rabbit model. Surg
Forum 1994; 45:378-380.
132. Buchwald H. Rohde TD. It's time to reconsider the implantable insulin pump. ASAIO J 1994;
40(4):917-918.
133. Buchwald H. Advances in management: A surgeon's perspective. Audio-Digest Gastroenterology
vol 8(12), 1994.
134. Esper E, Chan EK, Buchwald H. Natural history of atherosclerosis and hyperlipidemia in
heterozygous WHHL (WHHL-Hh) rabbits. I. The effects of aging and gender on plasma lipids and
lipoproteins. J Lab Clin Med 1993; 121(1):97-102.
135. Esper E, Runge WJ, Gunther R, Buchwald H. Natural history of atherosclerosis and hyperlipidemia
in heterozygous WHHL (WHHL-Hh) rabbits. II. Morphologic evaluation of spontaneously occurring
aortic and coronary lesions. J Lab Clin Med 1993; 121(1):103-110.
136. Stoller DK, Grorud CB, Michalek V, Buchwald H: Reduction of atherosclerosis with nonsteroidal
anti-inflammatory drugs. J Surg Res 1993; 54:7-11.
137. Campos CT, Buchwald H, and the POSCH Group. Effects of cholesterol lowering on mortality,
morbidity, and the arteriographic course of coronary atherosclerosis: The Program on the Surgical
Control of the Hyperlipidemias. Lipid Rev 1993; 6(4):4-9.
138. Matts JP, Karnegis JN, Campos CT, Fitch LL, Johnson JW, Buchwald H. Serum creatinine - an
independent predictor of overall and atherosclerotic coronary heart disease mortality in normotensive
survivors of a myocardial infarction. J Fam Pract 1993; 36(5):497-503.
139. Buchwald H. Overview. Proceedings from the 1992 Surgical Research and Education Symposium.
1993; 4:1-2.
140. Buchwald H. NIH funding: contracts, grants, and cooperative agreements. Proceedings from the
1992 Surgical Research and Education Symposium. 1993; 4:9-13.
141. Campos CT, Buchwald H. Lipid lowering and regression of atherosclerosis. partial ileal bypass
surgery. Controversies Card 1993; 4:9-12.
142. Cress AS, Wigness BD, Dorman FD, Rohde TD, Buchwald H. Portable data acquisition and control
apparatus for implanted drug infusion pump interrogation. Trans Am Soc Artif Intern Organs 1993;
39:M695-M698.
143. Buchwald H, Fitch LL, Matts JP, Hansen BJ, Stuenkel MR, and the POSCH Group. Perception of
quality of life before and after disclosure of a trials results. a report of the Program On The Surgical
Control of the Hyperlipidemias (POSCH). Controlled Clin Trials 1993; 14(6):500-510.
144. Zimmerman V, Campos CT, Buchwald H. Weight loss comparison of gastric bypass and Silastic®
ring vertical gastroplasty. 1992; Obes Surg 2:47-49.
145. Buchwald H, Rohde TD. Implantable pumps and other devices for chronic infusion. Choices and
issues. 1992; ASAIO J 38(1):3-5.

CURRICULUM VITAE
16
146. Buchwald H. Hypothesis: Cholesterol inhibition, cancer, and chemotherapy. Lancet 1992;
339:1154-1156.
147. Buchwald H, Fitch LL, Campos CT. Partial ileal bypass in the treatment of hypercholesterolemia. J
Fam Pract 1992; 35(1):69-76.
148. Campos CT, Buchwald H, and the POSCH Group. The Program on the Surgical Control of the
Hyperlipidemias (POSCH). Demonstration of the Beneficial Effects of Treatment of
Hypercholesterolemia. Cardiovasc Risk Fact 1992; 2(4):261-275.
149. Buchwald H, Matts JP, Fitch LL, Campos CT, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR,
Hunter DW, Pearce MB, Bissett JK, Edmiston WA, Sawin HS, Weber FJ, Varco RL, Campbell GS,
Yellin AE, Smink RD, Long JM, Hansen BJ, Chalmers TC, Meier P, Stamler J, and the POSCH
Group. Changes in sequential coronary arteriograms and subsequent coronary events. JAMA 1992;
268(11):1429-1433.
150. Wigness BD, Dorman FD, Rohde TD, Buchwald H. The spring-driven implantable pump: A low-
cost alternative. Am Soc Artif Intern Organs J 1992; 38(3):M454-M457.
151. Buchwald H, CT Campos, JP Matts, LL Fitch, JM Long, RL Varco, and the POSCH Group. Women
in the POSCH trial. Effects of aggressive cholesterol modification in women with coronary heart
disease. Ann Surg 1992; 216:389-98.
152. Buchwald H, Rohde TD, Kryjeski SR. Insulin infusion pumps for diabetes mellitus treatment. Lab
Med 1992; 23(10):652-657.
153. Buchwald H, Rohde TD. Implantable pumps: Recent progress and anticipated future advances.
Trans Am Soc Intern Organs 1992; 38:772-778.
154. Menchaca HJ, Morris TJ, Bourdages H, Neff T, Michalek VN, Brennan E, Buchwald H. Role of the
mechanism of cholesterol reduction on vein graft atherosclerosis. Surg Forum 1992; 43:351-2.
155. Obialo CI, Clayman RV, Matts JP, Fitch LL, Buchwald H, Gillis M, Hruska KA, and the POSCH
Group. Pathogenesis of nephrolithiasis post-partial ileal bypass surgery: Case-control study. Kidney
Int 1991; 39:1249-54.
156. Matts JP, Buchwald H, Fitch LL, Campos CT, Varco RL, Campbell GS, Pearce MB, Yellin AE,
Edmiston WA, Smink RD Jr, Sawin HS Jr, Hansen BJ, Long JM, and the POSCH Group. Program
on the Surgical Control of the Hyperlipidemias (POSCH): Patient entry characteristics. Control Clin
Trials 1991; 12:314-339.
157. Wigness BD, Dorman FD, Robinson HJ, Arendt EA, Oegema TR, Rohde TD, Buchwald H.
Catheter with an anchoring tip for chronic joint capsule perfusion. Trans Am Soc Intern Organs
1991; 37:M290-M292.
158. Karnegis JN, Matts JP, Tuna N, Amplatz K, and the POSCH Group. Positive and negative exercise
test results with and without exercise-induced angina in patients with one healed myocardial
infarction: Analysis of baseline variables and long-term prognosis. Am Heart J, 1991; 122(3):701-
708.
159. Menchaca HJ, Campos CT, Michalek VN, Buchwald H. Effects of immunomodulation by
cyclosporine on plasma lipoprotein levels and atheroslcerosis development. Surg Forum 1991;
42:356-7.

CURRICULUM VITAE
17
160. Morris TJ, Palm SL, Pena J, Furcht LT, Buchwald H. Inhibition of hepatoma tissue culture-4 cell
growth by lovastatin: A novel chemotherapeutic strategy. Surg Forum 1991; 42:452-4.
161. Buchwald H. POSCH: Just another study? Nutr Metab Cardiovas Dis 1991; 1:1.
162. Buchwald H, Campos CT. Remedial operations following surgery for morbid obesity. Obes Surg
1991; 1:337-361.
163. Menchaca HJ, Campos CT, Michalek VN, Buchwald H. Cyclosporine A retards the development of
atherosclerosis in diet-induced hypercholesterolemic rabbits. Curr Surg 1991; 48:486-89.
164. Buchwald H, Stoller DK, Campos CT, Matts JP, Varco RL. Partial ileal bypass for
hypercholesterolemia 20- to 26-year follow-up of the first 57 consecutive cases. Ann Surg 1990;
212(3):318-331.
165. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE,
Edmiston WA, Smink RD Jr, Sawin HS Jr, Campos CT, Hansen BJ, Tuna N, Karnegis JN, Sanmarco
ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Bissett JK, Weber FJ, Stevenson JW, Leon AS,
Chalmers TC, and the POSCH Group. Effect of partial ileal bypass surgery on mortality and
morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program
on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med 1990; 323:946-955.
166. Wigness BD, Dorman FD, Rohde TD, Buchwald H. In vitro and in vivo testing of a new valved
intravascular catheter design. Trans Am Soc Art Organs 1990; 35(3):M355-358.
167. Buchwald H. NHLBI Clinical Trials and Conflicts of Interest. Guest Editorial, Controlled Clin
Trials 1990; 11:217-222.
168. Campos CT, Matts JP, Fitch LL, Speech JC, Long JM, Buchwald H and the POSCH Group. Lipid
results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Surgery
1990; 108(4):601-611.
169. Stoller DK, Campos CT, Grorud CB, Michalek V, Buchwald H. Prednisone reduction of
atherosclerosis in diet-induced hypercholesterolemic rabbits: Does immunomodulation play a role?
Surg Forum 1990; 41:351-354.
170. Buchwald H, Rohde TD. Current status of implantable drug delivery systems for patients requiring
chronic drug administration. Intern Med Spec 1989; 10(4):182-212.
171. Campos CT, Matts JP, Fitch LL, Speech JC, Long JM, Buchwald H, and the POSCH Group.
Modification of plasma lipoproteins following partial ileal bypass five-year results of the Program on
the Surgical Control of the Hyperlipidemias. Atherosclerosis 1989; 8:769-774.
172. Buchwald H, Rohde TD, Kernstine KH. Insulin delivery by implanted pump: A chronic treatment
for diabetes. Trans Am Soc Intern Organs 1989; 35:5-7.
173. Buchwald H, Guzman E, Wigness BD, Dorman FD, Rohde TD. The Minnesota shunt. Trans Am
Soc Intern Organs 1989; 35(2):168-170.
174. Campos CT, Michalek VN, Matts JP, Buchwald H. Dietary marine oil supplements fail to affect
cholesterol metabolism or inhibit atherosclerosis in diet-induced hypercholesterolemic rabbits.
Surgery 1989; 106(2):177-184.
175. Buchwald H, Campos CT. Diverting cervical esophagostomy and construction and primary
reconstruction of esophageal continuity. Surg Gynecol Obst 1989; 169:361-362.

CURRICULUM VITAE
18
176. Buchwald H, Matts JP, Fitch LL, Varco RL, Campbell GS, Pearce M, Yellin A, Smink RD Jr, Sawin
HS Jr, Campos CT, Hansen BJ, Long JM, and the POSCH Group. Program on Surgical Control of
the Hyperlipidemias (POSCH): Design and methodology. J Clin Epidem 1989; 42(12):1111-1127.
177. Campos CT, Michalek VN, Fulco JM, Matts JP, Buchwald H. High-dose dietary marine oil inhibits
atherosclerosis in diet-induced hypercholesterolemic rabbits. Surg Forum 1989; 40:290-292.
178. Campos CT, Matts JP, Santilli SM, Fitch LL, Long JM, Speech JC, Buchwald H. Predictors of total
and LDL cholesterol change following partial ileal bypass. Am J Surg 1988; 155:138-146.
179. Kernstine K, Kryjeski S, Ekerholm P, Wigness B, Rohde T, Dorman F, Buchwald H. Restoration
and maintenance of intravenous insulin infusion in the vapor-pressure powered implantable infusion
device. Trans Am Soc Intern Organs 1988; 34(3):371-374.
180. Guzman E, Wigness BD, Dorman FD, Rohde TD, Buchwald H. Advances and new concepts in the
designing of peritoneovenous shunts for the treatment of refractory ascites. Trans Am Soc Intern
Organs 1988; 34(3):805-807.
181. Campos CT, Matts P, Fitch LL, Speech JC, Long JM, Buchwald H, POSCH Group. Normalization
of lipoproteins following partial ileal bypass in individual W.H.O. lipoprotein phenotypes. Curr Surg
1988; 45:380-382.
182. Tijerina OB, Dombrovskis S, Esper E, Matts JP, Campos CT, Buchwald H. Low plasma lipid levels
and increased cholesterol synthesis after partial ileal bypass plus Lovastatin in hypercholesterolemic
rabbits. Surgery 1988; 104(4):796-805.
183. Kernstine KH, Wigness BD, Sutherland DER, Dorman FD, Rohde TD, Buchwald H. Intravenous
delivery of cyclosporine: Long-term dog infusion by an implantable device. Surg Forum 1988;
39:379-382.
184. Campos CT, Matts JP, Fitch LL, Speech J, Long JM, Buchwald H, POSCH Group. Comparisons of
lipoprotein results in men and women after partial ileal bypass for hypercholesterolemia. Surg Forum
1988; 39:193-195.
185. Cowley SM, Somelofski C, Hill MN, Smith J, Buchwald H. Nursing and cardiovascular clinical trial
research: Collaborating for successful outcomes. Cardiovasc Nurs (Am Heart Assoc) 1988; 24(5);25-
30.
186. Esper E, Wigness BD, Dombrovskis S, Michalek V, Rohde TD, Buchwald H. A rabbit model for
implanting continuous drug infusion pumps. Trans Am Soc Intern Organs 1987; 10(1):28-32.
187. Esper E, Barichello A, Chan EK, Matts JP, Buchwald H. Synergistic lipid lowering effects of alfalfa
meal as an adjuvant to the partial ileal bypass operation. Surgery 1987; 102(1):39-51.
188. Campos CT, Matts JP, Fitch LL, Speech JC, Long JM, Buchwald HB and POSCH Group.
Lipoprotein modification achieved by partial ileal bypass: Five-year results of the POSCH trial.
Surgery 1987; 102(2);424-432.
189. Buchwald H, Matts JP, Hansen BJ, Long JM, Fitch LL and the POSCH Group. Program on the
Surgical Control of the Hyperlipidemias (POSCH): Recruitment experience. Control Clin Trials
1987; 8:94S-104S.
190. Kernstine KH, Kryjeski SR, Rohde TD, Goldenberg FJ, Buchwald H. Multiple regression analysis
to identify factors important for maintaining insulin pump therapy. Trans Am Soc Intern Organs
1987; 10(3):463-471.

CURRICULUM VITAE
19
191. Rohde TD, Kernstine KH, Wigness BD, Kryjeski SR, Dorman FD, Goldenberg JF, Buchwald H.
Improved glycerol/insulin formulation for use in implantable pumps. Trans Am Soc Intern Organs
1987; 10(3):316-318.
192. Bissett JK, Matts J, Sharma B, POSCH Group. Residual myocardial jeopardy in patients with Q-
wave and non-Q-wave infarctions. Brit Heart J 1987; 58:460-464.
193. Buchwald H. Insulin Replacement: Bionic or Natural. Trans Am Soc Intern Organs 1987; 33:806-
812.
194. Buchwald H, Rohde TD, Dorman F, Barbosa JJ, Rupp WM, Goldenberg FJ, Chute EP. Implantable
infusion systems and the application of the implantable infusion pump for insulin delivery. Acta Chir
Italia 1986; 42:1167-1171.
195. Rucker RD Jr, Chan EK, Chute EP, Varco RL, Buchwald H. The use of jejunoileal bypass, loop
gastric bypass and Roux-en-Y gastric bypass to achieve similar weight reduction in morbidly obese
individuals. Clin Nutr 1986; 5(Suppl):101-105.
196. Long J, POSCH Group. The POSCH data processing experience. J Med Syst 1986; 10(2):173-183.
197. Karnegis JN, Matts JP, Tuna N, Amplatz K, the POSCH Group. Relation between Q-QS changes in
the rest electrocardiogram and left ventricular function with healed myocardial infarction. Am J Card
1986; 58:399-405.
198. Mann HJ, Buchwald H. Cefamandol distribution in serum, adipose tissue, and wound drainage in
morbidly obese patients. Drug Intell Clin Pharm 1986; 20:869-873.
199. Esper E, Barichello A, Chan EK, Matts JP, Buchwald H. Alfalfa meal as an adjuvant to partial ileal
bypass for lipid lowering. Surg Forum 1986; 37:21-24.
200. Kernstine KH, Kryjeski SR, Wigness BD, Rohde TD, Dorman FD, Chute EP, Rupp WM, Buchwald
H. Implantable continuous intravenous insulin infusion device: Restoration of flow after slow-down.
Trans Am Soc Intern Organs 1986; 32:511-514.
201. Wigness BD, Rohde TD, Dorman FD, Buchwald H. Use of polyethylene-lined silicone rubber
cannulae in long-term insulin infusion in the dog. Trans Am Soc Intern Organs 1986; 32:363-366.
202. Guzman E, Wigness BD, Dorman FD, Rohde TD, Buchwald H. A new peritoneovenous shunt.
Surgery 1986; 100(4):691-696.
203. Roemeling RV, Hrushesky WJM, Kennedy BJ, Buchwald H. Programmed automatic FUDR
chronotherapy improves therapeutic index. Surg Forum 1986; 37:400-2.
204. Roemeling RV, Langevin TR, Buchwald H, Grage T, Kennedy BJ, Hrushesky WJM. Automatic
chronotherapy using an implanted programmable pump. Proc Am Soc Clin Oncol 1986; 5:83.
205. Roemeling VR, MacDonald M, Langevin T, Buchwald H, Hrushesky WJM. Chemotherapy via
implanted infusion pump: New perspectives for delivery of long-term continuous treatment.
Oncology Nursing Forum 1986; 13(2):17-24.
206. Karnegis JN, Matts JP, Tuna N, Amplatz K, Moore RB, Buchwald H, POSCH Group. Quantitative
assessment of left ventricular function after myocardial infarction using the Minnesota Q-QS codes
for resting electrocardiograms. Catheter Cardiovasc Diagn 1985; 11:393-400.
207. McCarthy HB, Rucker RD, Chan EK, Rupp WM, Snover D, Goodale RL, Buchwald H. Gastritis
after gastric bypass surgery. Surgery 1985; 98:68-71.

CURRICULUM VITAE
20
208. Buchwald H, Chute EP. Implantable infusion devices: Gadgets for the future. Am Coll Surg
Bulletin. 1985; 70(5):16-17.
209. Buchwald H, Chute EP, Rupp WM, Barbosa JJ, Dorman FD, Goldenberg FJ, Rohde TD.
Implantable infusion pump for insulin delivery: past, present, and future. Life Support Syst 1985;
3(1):51-53.
210. Tarsio JF, Wigness BD, Rohde TD, Rupp WM, Buchwald H. Nonenzymatic glycation of fibronectin
and alterations in the molecular association of cell matrix and basement membrane components in
diabetes mellitus. Diabetes 1985; 34(5):477-484.
211. Karnegis JN, Matts J, Tuna M, POSCH Group. Development and evolution of electrocardiographic
Minnesota Q-QS codes in patients with acute myocardial infarction. Am Heart J 1985; 110:452-459.
212. Chute EP, Barbosa JJ, Rupp WM, Rohde TD, Goldenberg FJ, Hitchcock CR, Buchwald H.
Reduction of plasma cholesterol and LDL-cholesterol by continuous intravenous insulin infusion.
Surgery 1985; 98(4):656-661.
213. Buchwald H, Fitch L, Varco RL. lleal bypass for hyperlipidemia. World J Surg 1985; 9:850-859.
214. Buchwald H, Chute EP, Goldenberg FJ, Hitchcock CR, Hoogwerf B, Barbosa JJ, Rupp WM, Rohde
TD. Implantable infusion pump management of insulin resistant diabetes mellitus. Ann Surg 1985;
202(3):278-282.
215. Buchwald H, Fitch L, Varco RL. Surgical intervention in atherosclerosis: partial ileal bypass and the
Program of Surgical Control of the Hyperlipidemias (POSCH). Pharmac Ther 1985; 29:93-109.
216. Guzman E, Wigness BD, Rohde TD, Buchwald H. A new peritoneovenous shunt catheter. Trans
Am Soc Artif Intern Organs 1985; 31:111-115.
217. Wigness BD, Aeder M, Chute EP, Hesse U, Sutherland DER, Dorman FD, Rohde TD, Buchwald H.
Continuous intravascular cyclosporine infusion by implantable pump. Trans Am Soc Artif Intern
Organs 1985; 31:136:139.
218. Chute EP, Barbosa JJ, Rupp WM, Rohde TD, Bordewich P, Hitchcock CR, Goldenberg FJ,
Buchwald H. Anti-insulin antibody titres after one year of intravenous insulin infusion by
implantable pump. Surg Forum 1985; 36:189-191.
219. Buchwald H, Rohde TD. Implantable drug infusion devices. Surgical Rounds. July 1984; 16-23.
220. Buchwald H, Rohde TD. Implantable infusion pumps. Adv Surg 1984; 18:177-221.
221. Buchwald H, Rohde TD. Implantable drug infusion technology: a challenge to the health-care
industry. Editorial, Med Device Diag Ind 1984; 6(1):10-11.
222. Rucker RD Jr, Chan EK, Horstmann J, Chute EP, Varco, RL, Buchwald H. Searching for the best
weight reduction operation. Surgery 1984; 96:624-630.
223. Chan EK, Mackey MA, Snover DC, Schneider PD, Rucker RD Jr, Allen CE, Buchwald H.
Suppression of weight gain by glucagon in obese Zucker rats. Exp Molec Path 1984; 40:320-327.
224. Chute EP, Rupp WM, Rohde TD, Goldenberg FJ, Bordewich PH, Hitchcock CR, Blackshear PJ,
Buchwald H. Continuous single-rate long-term insulin infusion using a totally implantable pump.
Trans Am Soc Artif Intern Organs 1984; 30:387-389.

CURRICULUM VITAE
21
225. Mauer SM, Buchwald H, Groppoli TJ, Rohde TD, Wigness BD, Rupp WM, Steffes MW. Failure to
find amyloidosis in dogs treated with long-term intravenous insulin delivered by a totally implantable
pump. Diabetologia 1983; 25:448-450.
226. Buchwald H, Moore RB, Rucker RD, Amplatz K, Casteneda WR, Francoz RA, Pasternac RC, Varco
RL, POSCH Group. Clinical angiographic regression of atherosclerosis after partial ileal bypass.
Atherosclerosis 1983; 46:117-128.
227. Wigness BD, Rupp WM, Rohde TD, Steffes MW, Mauer SM, Dorman FD, Chapman RC, Blackshear
PJ, Buchwald H. Reduced incidence of clinical hypoglycemia in diabetic dogs receiving intensive
insulin therapy by implantable pump. Trans Am Soc Artif Intern Organs 1983; 29:496-500.
228. Rupp WM, Wigness BD, Anderson MH, Dorman FD, Rohde TD, Buchwald H. Improved catheter
patency by means of a simple check-valve mechanism. Trans Am Soc Artif Intern Organs 1983;
29:275-27.
229. Rohde TD, Wigness BD, Rupp WM, Mauer SM, Dorman FD, Chapman RC, Blackshear PJ,
Buchwald H. Control of glycemia in four routes of insulin administration in diabetic dogs. Trans
Am Soc Artif Intern Organs 1983; 29:720-723.
230. Rupp WM, Rohde TD, Wigness BD, Blackshear PJ, Buchwald H. Clinical experience with insulin-
glycerol solution in an implantable insulin pump. Trans Am Soc Artif Intern Organs 1983; 29:492-
495.
231. Blackshear PJ, Rohde TD, Palmer JL, Wigness BD, Rupp WM, Buchwald H. Glycerol prevents
insulin precipitation and interruption of flow in an implantable insulin infusion pump. Diabetes Care
1983; 6(4):387-392.
232. Buchwald H. Frontiers in artificial organ research: Current overview of implantable infusion
devices. Trans Am Soc Artif Intern Organs 1983; 29:1-3.
233. Karnegis JN, Matts J, Tuna N, Amplatz K, Moore RB, Buchwald H, and the POSCH group.
Directional ST-segment deviation in graded exercise tests correlated with motion of the individual
segments of the left ventricular wall. Am J Card 1983; 52:449-452.
234. Barichello AW, Chan EK, Moore RB, Buchwald H. Influence of partial ileal bypass and/or alfalfa
on the cholesterol excretion and bile acid turnover rate of rats. Surg Forum 1983; 34:191-194.
235. Buchwald H, Rohde TD, Wigness BD, Goldenberg FJ, Dorman FD, Hitchcock CR, Chute EP,
Barbosa JJ, Blackshear PJ, Rupp WM. Treatment of type I diabetes mellitus and mild nephropathy
with a totally implantable insulin infusion device. Diabetic Nephropathy 1983; 2(4):19-22.
236. Rupp WM, McCarthy HB, Barbosa JJ, Blackshear PJ, Rohde TD, Goldenberg FJ, Buchwald H.
Evidence for improved islet cell function in Type II diabetic patients treated by implantable insulin
infusion device. Surg Forum 1982; 33:230-232.
237. Barichello AW, Chan EK, Moore RB, Buchwald H. Adjuvant effect of alfalfa to partial ileal bypass
in the control of hypercholesterolemia in rabbits fed a semipurified diet. Surg Forum 1982; 33:199-
201.
238. Wigness BD, Dorman FD, Anderson M, Rohde TD, McCarthy HB, Rupp WM, Buchwald H.
Bidirectional implantable vascular access modality. Trans Am Soc Artif Intern Organs 1982; 28:54-
57.

CURRICULUM VITAE
22
239. Rohde TD, Wigness BD, Dorman FD, Rupp WM, Arlt G, Steffes MW, Blackshear PJ, Tirrell MV,
Buchwald H. Glucoregulation in the dog by implantable pump and conventional means. Trans Am
Soc Artif Intern Organs 1982; 28:249-252.
240. Rucker RD Jr, Guzman IJ, Snover D, Schneider PD, Chan EK, Moore RB, Varco RL, Buchwald H.
Long-term hypolipidemic effect of portacaval transposition and distal intestinal resection without
change in liver function tests. J Surg Res 1982; 32:423-428.
241. Buchwald H, Moore RB, Matts JP, Long JM, Varco RL, Campbell GS, Pearce MB, Yellin AE,
Blankenhorn DH, Holmes WL, Smink RD, Sawin HS, POSCH. The Program on the Surgical Control
of the Hyperlipidemias: A status report. Surgery 1982; 92(4):654-662.
242. Rucker RD Jr, Horstmann J, Schneider PD, Varco RL, Buchwald H. Comparisons between
jejunoileal and gastric bypass operations for morbid obesity. Surgery 1982; 92:241-249.
243. Steffes MW, Buchwald H, Wigness BD, Groppoli TJ, Rupp WM, Rohde TD, Blackshear PJ, Mauer
SM. Diabetic nephropathy in the uninephrectomized dog: Microscopic lesions after one year.
Kidney Int 1982; 21:721-724.
244. Rupp WM, Barbosa JJ, Blackshear PJ, McCarthy HB, Rohde TD, Goldenberg FJ, Rublein TG,
Dorman FD, Buchwald H. The use of an implantable insulin pump in the treatment of Type II
diabetes. N Engl J Med 1982; 307:265-270.
245. Rupp WM, McCarthy HB, Rohde TD, Blackshear PJ, Goldenberg FJ, Buchwald H. Risk of
osteoporosis in patients treated with long-term intravenous heparin therapy. Curr Surg 1982;
39(6):419-422.
246. Buchwald H, Fitch L, Moore RB. Overview of randomized clinical trials of lipid intervention for
atherosclerotic cardiovascular disease. Control Clin Trials 1982; 3:271-283.
247. Wigness BD, Mauer SM, Rupp WM, Rohde TD, Steffes MW, Blackshear PJ, Rucker RD, Jeraj K,
Buchwald H. A double balloon catheter technique for alloxan diabetogenesis in the dog. Surg
Gynecol Obstet 1982; 155:860-864.
248. Buchwald H, Rupp WM, Rohde TD, Barbosa JJ, Wigness BD, Dorman FD, McCarthy HB,
Goldenberg FJ, Blackshear PJ, Varco RL, Steffes MW, Mauer SM. Implantable insulin pump.
Insulin infusion in animals and man. Trans Am Soc Artif Intern Organs 1982; 28:687-690.
249. Buchwald H, Rucker RD Jr. The history of metabolic surgery for morbid obesity. World J Surg
1981; 5(6):781-787.
250. Sirtori CR, Ghiselli GC, Catapano AL, Lovati MR, Fragiacomo C, Fox U, Majone G, Buchwald H.
Reduced apoprotein B and increased lipoprotein turnover in cholesterol fed rabbits after partial ileal
bypass. Surgery 1981; 89:243-251.
251. Buchwald H, Barbosa J, Varco RL, Rohde TD, Rupp WM, Schwartz RA, Goldenberg FJ, Rublein
TG, Blackshear PJ. Treatment of a Type II diabetic patient by means of a totally implantable insulin
infusion device. Lancet 1981; 8232:1233-1235.
252. Rucker RD Jr, Goldenberg F, Varco RL, Buchwald H. Lipid effects of obesity operations. J Surg
Res 1981; 30:229-235.
253. Blackshear PJ, Rohde TD, Dorman FD, Buchwald H. An implantable pump for long-term
intravascular drug infusion. Med Instrum 1981; 15(4):226-228.

CURRICULUM VITAE
23
254. Buchwald H. The Scientist-Surgeon. Am J Surg 1981; 142:245-246.
255. Schwartz MZ, Rucker RD Jr, Schneider PD, Coyle JJ, Guzman IJ, Varco RL, Buchwald H.
Management of morbid obesity by jejunoileal bypass. World J Surg 1981; 5(6):807-816.
256. Buchwald H, Rucker RD, Schwartz MZ, Varco RL. Positive results of jejunoileal bypass surgery:
Emphasis on lipids with comparison to gastric bypass. Intl J Obes 1981; 5:399-404.
257. Dorman FD, Rohde TD, Arlt GJ, Wigness BD, Prosl FR, Blackshear PJ, Buchwald H. A two-phase
fluid powered insulin infusion pump with basal-bolus capability which compensates for pressure and
temperature variability. Trans Am Soc Artif Intern Organs 1981; 27:236-240.
258. Long JM, Brashear JR, Matts JP, Bearman JE, and the POSCH Group. The POSCH information
management system. Experience with alternative approaches. J Med Syst 1980; 4:355-366.
259. Buchwald H. Jejunoileal bypass for the treatment of morbid obesity. Int Surg 1980;65(2):103-105.
260. Buchwald H, Grage TB, Vassilopoulos PP, Rohde TD, Schneider PD, Varco RL, Blackshear PJ.
Intra-arterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump.
Cancer 1980; 45:866-869.
261. Moore RB, Buchwald H, Varco RL, POSCH Group. The effect of partial ileal bypass on plasma
lipoproteins. Circulation 1980; 62:469-476.
262. Buchwald H, Rohde TD, Varco RL, Schneider PD, Blackshear PJ. Long-term continuous
intravenous heparin administration by an implantable infusion pump in ambulatory patients with
recurrent venous thrombosis. Surgery 1980; 88:507-516.
263. Buchwald H. True informed consent in surgical treatment of morbid obesity: The current case for
both jejunoileal bypass and gastric bypass. Am J Clin Nutr 1980; 33:482-494.
264. Leon GR, Eckert ED, Teed D, Buchwald H. Body image, personality, and life event changes after
jejunoileal bypass surgery for massive obesity. MN Med 1980; 63:31-34.
265. Schneider PD, Chan EK, Guzman IJ, Rucker RD, Varco RL, Buchwald H. Retarding Novikoff
tumor growth by altering host rat cholesterol metabolism. Surgery1980; 87:409-416.
266. Guzman IJ, Schneider PD, Coyle JJ, Varco RL, Buchwald H. Combined hypolipidemia of
portacaval transposition and ileal resection in the dog. Surg Gynecol Obstet 1980; 150:475-480.
267. Bond JH, Currier BE, Buchwald H, Levitt MD. Colonic conservation of malabsorbed carbohydrate.
Gastroenterology 1980; 78(3):444-447.
268. Buchwald H, Moore RB, Varco RL. Partial ileal bypass: A test of the lipid-atherosclerosis
hypothesis. Atherosclerosis V, 1980; p462-465. (Proceedings of the 5th
International Symposium on
Atherosclerosis)
269. Buchwald H, Rucker RD, Moore RB, Varco RL. Changes in atherosclerotic lesions following
surgical cholesterol reduction. Atherosclerosis V, 1980; p735-8. (Proceedings of the 5th
International
Symposium on Atherosclerosis)
270. Buchwald H, Rohde TD, Dorman FD, Skakoon JG, Wigness BD, Prosl FR, Tucker EM, Rublein TG,
Blackshear PJ, Varco RL. A totally implantable drug infusion device: Laboratory and clinical
experience using a model with single flow rate and new design for modulated insulin infusion.
Diabetes Care 1980; 3:351-358.

CURRICULUM VITAE
24
271. Leon GR, Eckert ED, Teed D, Buchwald H. Changes in body images and other psychological
factors after intestinal bypass surgery for massive obesity. J Behavioral Med 1979; 2:39-55.
272. Moore RB, Long JM, Matts JP, Amplatz K, Varco RL, Buchwald H, POSCH. Plasma lipoproteins
and coronary arteriography in subjects in the Program on the Surgical Control of the
Hyperlipidemias: Preliminary report. Atherosclerosis 1979; 32:101-119.
273. Blackshear PJ, Rohde TD, Grotting JC, Dorman FD, Perkins PR, Varco RL, Buchwald H. Control
of blood glucose in experimental diabetes by means of a totally implantable insulin infusion device.
Diabetes 1979; 28:634-639.
274. Buchwald H, Varco RL. Jejuno-ileal bypass for morbid obesity: Successes and failures.
Proceedings of the Xth
European Congress of the International College of Surgeons, 1979; 447-450.
275. Coyle JJ, Guzman IJ, Varco RL, Buchwald H. Cholesterol pool sizes and turnover following
portacaval shunt in the dog. Surg Gynecol Obstet 1979; 148:723-727.
276. Rucker RD, Schneider PD, Stocks TG, Guzman IG, Varco RL, Buchwald H. Stimulation of hepatic
cholesterol synthesis in normal rats by cross-circulation with ileal bypassed parabiont partners. Surg
Forum 1979; 30:384-385.
277. Schneider PD, Guzman IJ, Rucker RD, Stocks TG, Varco RL, Buchwald H. Increased hepatic
cholesterol synthesis in normal rats by cross-circulation with ileal bypassed partners. Atherosclerosis
1979; 34:383-389.
278. Blackshear PJ, Rohde TD, Prosl F, Buchwald H. The implantable infusion pump: A new concept in
drug delivery. Med Progr Technol 1979; 6:149-161.
279. Marubbio AT, Rucker RD Jr, Schneider PD, Horstmann JP, Varco RL, Buchwald H. The liver in
morbid obesity and following bypass surgery for obesity. Surg Clin N Am 1979; 59:1079-1093.
280. Buchwald H. Surgical approaches for failed jejunoileal bypass and failed gastric bypass. Surg Cl N
Am 1979; 59:1121-1130.
281. Buchwald H. Lipid-Atherosclerosis Symposium: Overview and Dedication. Arch Surg, 1978;
113(1):18-20.
282. Clayman RV, Buchwald H, Varco RL, DeWolf WC, Williams RD. Urolithiasis in patients with a
jejunoileal bypass. Surg Gynecol Obstet 1978; 147:225-230.
283. Perkins PR, Dorman FD, Rohde TD, Blackshear PJ, Blackshear PL Jr, Varco RL, Buchwald H.
Design and initial testing of a totally implantable transcutaneously controllable insulin delivery
device. Trans Am Soc Artif Intern Organs 1978; 24:229-231..
284. Coyle JJ, Varco RL, Buchwald H. Mechanisms of cholesterol-controlling operation in the rat. Surg
Forum 1978; 29:84-86.
285. Buchwald H, Moore RB, Varco RL. Maximum lipid reduction by partial ileal bypass. A test of the
lipid hypothesis of atherogenesis. Lipids 1977; 12:53-58.
286. Feinberg SB, Schwartz MZ, Clifford S, Buchwald H, Varco RL. The significance of pneumatosis
intestinalis following jejuno-ileal bypass. Am J Surg 1977; 133:149-152.
287. Blackshear PJ, Rohde TD, Varco RL, Buchwald H. The effect of continuous heparin infusion for
one year on serum cholesterol and triglyceride concentrations in the dog. Atherosclerosis 1977;
26:23-27.

CURRICULUM VITAE
25
288. Rohde TD, Blackshear PJ, Varco RL, Buchwald H. Protracted parenteral drug infusion in
ambulatory subjects using an implantable infusion pump. Trans Am Soc Artif Intern Organs 1977;
23:13-16.
289. Coyle JJ, Varco RL, Buchwald H. Vitamin Bl2 absorption following human intestinal bypass
surgery. Am J Digest Dis 1977; 22:1069-1071.
290. Guzman IJ, Fitch LL, Varco RL, Buchwald H. Small bowel length in hyperlipidemia and massive
obesity. Am J Clin Nutr 1977; 30:1006-1008.
291. Rohde TD, Blackshear PJ, Varco RL, Buchwald H. One year of heparin anticoagulation in an
ambulatory subject using a totally implantable pump. MN Med 1977; 60:719-722.
292. Guzman IJ, Coyle JJ, Schneider PD, Varco RL, Buchwald H. The effect of selective visceral caval
shunt on plasma lipids and cholesterol dynamics. Surgery 1977; 82:42-50.
293. Coyle JJ, Guzman IJ, Hanson R, Varco RL, Buchwald H. Sterol dynamics following portacaval
shunt. J Surg Res 1977; 22:348-351.
294. Guzman IJ, Gold JH, Rosai J, Schneider PD, Varco RL, Buchwald H. Benign hepatocellular tumors.
Surgery 1977; 82:495-503.
295. Coyle JJ, Guzman IJ, Varco RL, Buchwald H. Cholesterol kinetics following portacaval shunt in the
dog. Surg Forum 1977; 28:404-405.
296. Schwartz MZ, Varco RL, Buchwald H. Treatment of heterozygous type II hyperlipidemia by partial
ileal bypass in a pediatric population. J Pediatr Surg 1976; 11:411-418.
297. Coyle JJ, Schwartz MZ, Eisenberg MM, Varco RL, Buchwald H. Fasting and stimulated serum
gastrin levels in humans following jejunoileal bypass. J Surg Res 1976; 20:365-368.
298. Coyle JJ, Schwartz MZ, Marubbio AT, Varco RL, Buchwald H. The effect of portacaval shunt on
plasma lipids and tissue cholesterol synthesis in the dog. Surgery 1976; 80:54-60.
299. Marubbio AT, Buchwald H, Schwartz MZ, Varco RL. Hepatic lesions of central peri-cellular
fibrosis in morbid obesity and after jejunoileal bypass. Am J Clin Pathol 1976; 66:684-691.
300. Coyle JJ, Varco RL, Buchwald H. The effect of bile acids on hepatic cholesterol synthesis in the
partial ileal bypass rabbit. Surg Forum 1976, 27:447-449.
301. Guzman IJ, Coyle JJ, Varco RL, Buchwald H. Cholesterol metabolism after portacaval shunt and
partial ileal bypass in the rabbit. Surg Forum 1976; 27:78-79.
302. Buchwald H, Varco RL, Moore RB, Schwartz M. Intestinal bypass procedures—Partial ileal bypass
for hyperlipidemia and jejunoileal bypass for obesity. Curr Probl Surg, April, 1975; 1-51.
303. Blackshear PJ, Rohde RD, Varco RL, Buchwald H. One year continuous heparinization in the dog
using a totally implantable infusion pump. Surg Gynecol Obstet 1975; 141:176-186.
304. Coyle JJ, Varco RL, Buchwald H. Gastric secretion and serum gastrin in human small bowel bypass.
Arch Surg 1975; 110:1036-1038.
305. Guzman IJ, Varco RL, Buchwald H. Factors determining weight loss after jejuno-ileal bypass for
obesity. J Surg Res 1975; 18:399-403.

CURRICULUM VITAE
26
306. Rohde TD, Blackshear PJ, Varco RL, Buchwald H. Chronic heparin anticoagulant in dogs by
continuous infusion with a totally implantable pump. Trans Amer Soc Artif Int Organs 1975; 21:510-
515.
307. Buchwald H, Lober PH, Varco RL. Liver biopsy findings in 77 consecutive patients undergoing
jejuno-ileal bypass for morbid obesity. Am J Surg 1974; 127:48-52.
308. Buchwald H, Gebhard RL, Varco RL. Relative secretion of cholesterol -4-14c in the bile and upper
and lower small intestinal washings of the bile fistula rabbit. Surgery 1974; 75:266273.
309. Steinbach JH, Blackshear PL Jr, Varco RL, Buchwald H. High blood cholesterol reduces in-vitro
blood oxygen delivery. J Surg Res 1974; 16:134-139.
310. Buchwald H, Moore RB, Varco RL. Surgical treatment of hyperlipidemias. Part I Apologia; Part II -
The laboratory experience; Part III- Clinical status of the partial ileal bypass operation. Circulation
1974; 49(I):l-37.
311. Buchwald H, Coyle J, Varco RL. Effect of small bowel bypass on gastric secretory function:
Postintestinal exclusion hypersecretion, a phenomenon in search of a syndrome. Surgery 1974;
75:821-828.
312. Buchwald H, Moore RB, Varco RL. Ten years clinical experience with partial ileal bypass in
management of the hyperlipidemias. Ann Surg 1974; 180:384-392.
313. Schwartz ML, Sheldon D, Dorman F, Blackshear PL Jr, Varco RL, Buchwald H, Nicoloff DM.
Local anticoagulation of prosthetic heart valves. Circulation 1973; 48(Suppl 3):85-89.
314. Schwartz MZ, Varco RL, Buchwald H. Preoperative preparation, operative technique, and
postoperative care of patients undergoing jejuno-ileal bypass for massive exogenous obesity. J Surg
Res 1973; 14:147-50.
315. Blackshear PJ, Dorman FD, Blackshear PL Jr, Varco RL, Buchwald H. The design and initial
testing of an implantable infusion pump. Surg Gynecol Obstet 1972; 134:51-56.
316. Buchwald H, Moore RB, Bertish J, Varco RL. Effect of ileal bypass on cholesterol levels,
atherosclerosis and growth in the infant rabbit. Ann Surg 1972; 175:311-319.
317. Schwartz MZ, Moore RB, Varco RL, Buchwald H. Cholesterol dynamics following partial ileal
bypass versus partial ileal excision in the rabbit. Surgery 1972; 71:547-555.
318. Knight L, Scheibel R, Amplatz K, Varco RL, Buchwald H. Radiographic appraisal of the Minnesota
partial ileal bypass study. Surg Forum 1972; 23:141-142.
319. Buchwald H. Functional surgery of the small intestine. Arch Françaises des Maladies de l'Appareil
Digestif, Paris, 1972; 61(9):591-592.
320. Buchwald H, Varco RL. A bypass operation for obese hyperlipidemic patients. Surgery 1971;
70;62-70.
321. Buchwald H, Varco RL. Vll. Gastrointestinal and Biliary: Human gastric secretory studies following
distal small bowel bypass. Curr Top Surg Res 1971; 3:409-415.
322. Schwartz MZ, Varco RL, Buchwald H. Liver function and morphology following distal ileal
excision in the rabbit. Surg Forum 1971; 22:355-356.
323. Buchwald H. The visible and palpable stigmata of hyperlipidemia. Derma Dig 1970; 9:65-70.

CURRICULUM VITAE
27
324. Buchwald H. The lipid clinic concept. Hospital Practice, November, 1970, 119-130.
325. Schwartz MZ, Moore RB, Buchwald H. Cholesterol excretion following chronic ileal bypass.
Surgery 1970; 67:346-349.
326. Gebhard RL, Buchwald H. Cholesterol absorption following reversal of the upper and lower halves
of the small intestine. Surgery 1970; 67:474-477.
327. Moore RB, Frantz ID Jr, Varco RL, Buchwald H. Cholesterol dynamics after partial ileal bypass.
Proceedings of the Second International Symposium on Atherosclerosis, ED: RJ Jones, 1970; 295-
300.
328. Buchwald H, Moore RB, Frantz ID Jr, Varco RL. Clinical experience with partial ileal bypass in
treatment of the hyperlipidemias. Proceedings of the Second International Symposium on
Atherosclerosis, ED: RJ Jones, 1970; 464-468.
329. Buchwald H, Moore RB, Frantz ID Jr, Varco RL. Cholesterol reduction by partial ileal bypass in a
pediatric population. Surgery 1970; 68:1101-1111.
330. Schwartz MZ, Moore RB, Buchwald H. Cholesterol synthesis and turnover rates following ileal
bypass and ileal excision in the rabbit. Surg Forum 1970; 21:400-402.
331. Blackshear PJ, Dorman FD, Blackshear PL Jr, Varco RL, Buchwald H. A permanently implantable
self-recycling low flow constant rate multipurpose infusion pump of simple design. Surg Forum
1970; 21:136-137.
332. Moore RB, Frantz ID Jr, Buchwald H. Changes in cholesterol pool size, turnover rate, and fecal bile
acid and sterol excretion after partial ileal bypass in hypercholesterolemic patients. Surgery 1969;
65:98-108.
333. Buchwald H, Moore RB, Lee GB, Baltaxe H, Amplatz K, Frantz ID Jr, Varco RL. Five years
experience with the use of partial ileal bypass in the treatment of hypercholesterolemia and
atherosclerosis. IV. Asian-Pacific Congress of Cardiology Proceedings, Israel J Med Sci 1969;
5:760-765.
334. Baltaxe H, Amplatz K, Varco RL, Buchwald H. Coronary arteriography in hypercholesterolemic
patients. Am J Roentg 1969; 105:784-790.
335. Buchwald H: Editorial: lleal bypass in the treatment of the hyperlipidemias. J Atheroscler Res
1969; 10:1-4.
336. Merkel FK, Buchwald H, Najarian JS. The diagnosis and surgical treatment of renovascular
hypertension. So Dak J Med 1969; 22:13-18.
337. Buchwald H, Bertish J, Moore RB. Ileal bypass in the infant rabbit with pediatric clinical findings.
Surg Forum 1969; 20:394-396.
338. Buchwald H. The dumping syndrome and its treatment: A review and presentation of cases. Am J
Surg 1968; 116:81-88.
339. Buchwald H, Lee GB, Amplatz K, Moore RB, Frantz ID Jr, Varco RL. Severe atherosclerotic
cardiovascular disease in a 14-year old homozygous familial hypercholesterolemic. MN Med 1968;
51:477-481.

CURRICULUM VITAE
28
340. Buchwald H, Frantz ID Jr, Gebhard RL, Moore RB. Effect of ileal bypass versus ileal excision on
cholesterol synthesis and whole blood cholesterol concentrations in the rabbit. Surgery 1968; 64:126-
133.
341. Buchwald H, Moore RB, Lee GB, Frantz ID Jr, Varco RL. Treatment of hypercholesterolemia:
Combined dietary, surgical, and bile salt binding resin therapy. Arch Surg 1968; 97:275-282.
342. Schwartz MZ, Moore RB, Buchwald H. Cholesterol excretion in the chronically bypassed ileum.
Surg Forum 1968; 19:306-307.
343. Gebhard RL, Buchwald H. Cholesterol absorption after reversal of the upper and lower halves of the
small intestine. Surg Forum 1968; 19:304-305.
344. Buchwald H. The development of the subtotal ileal bypass operation as a therapeutic approach to
hypercholesterolemia and atherosclerosis: A review. Dis Chest 1967; 51:459-465.
345. Buchwald H, Gebhard RL. The essential role of bile in the intestinal absorption of cholesterol.
Surgery 1967; 61:791-794.
346. Buchwald H, Varco RL. Partial ileal bypass for hypercholesterolemia and atherosclerosis. Surg
Gynecol Obstet 1967; 124:1231-1238.
347. Leonard AS, Levine AS, Wittner R, Buchwald H, Varco RL. Massive small bowel resections:
Operative and dietary management. Arch Surg 1967; 95:429-435,
348. Buchwald H, Frantz ID Jr, Gebhard RL, Moore RB. Ileal bypass versus ileal excision: Effect on
cholesterol synthesis and whole blood cholesterol concentrations in the rabbit. Preliminary report.
Surg Clin N Am 1967; 47:1353-1362,
349. Buchwald H, Gebhard RL. Localization of bile salt absorption in-vivo in the rabbit. Ann Surg 1968;
167:191-198.
350. Buchwald H, Varco RL. lleal bypass in patients with hypercholesterolemia and atherosclerosis:
Preliminary report on therapeutic potential. JAMA 1966; 196:627-630.
351. Buchwald H, Gebhard RL, Carey JB Jr. Bile salts absorption following intestinal bypass. Surg
Forum 1966; 17:27-28.
352. Buchwald H. Myocardial infarction in rabbits induced solely by a hypercholesterolemic diet. J
Atheroscler Res 1965; 4:407-419.
353. Buchwald H. The effect of ileal bypass on atherosclerosis and hypercholesterolemia in the rabbit.
Surgery 1965; 58:22-36.
354. Buchwald H. A modification of the traditional Thiry-Vella loop for precise quantitative absorption
studies. Proc Soc Exp Biol Med 1964; 115:770-771.
355. Buchwald H. Lowering of cholesterol absorption and blood levels by ileal exclusion: Experimental
basis and preliminary clinical report. Circulation 1964; 29:713-720.
356. Buchwald H, Gebhard R. Effect of intestinal bypass on cholesterol absorption and blood levels in
the rabbit. Am J Physiol 1964; 207:567-572.
357. Buchwald H, Aust JB. Use of chemosurgery with Mohs' paste in advanced carcinoma of the head.
Am J Surg 1964; 108:589-591.

CURRICULUM VITAE
29
358. Buchwald H. Vitamin Bl2 absorption deficiency following bypass of the ileum. Am J Dig Dis
1964; 9:755-759.
359. Buchwald H, Varco RL. Ileal bypass in lowering high cholesterol levels. Surg Forum 1964; 15:289-
291.
360. Buchwald H. The dumping syndrome: An evaluation of pH in its genesis. Surgery 1963;
54:483489.
361. Buchwald H, Aust JB. Carcinoma of the ethmoid sinuses. MN Med 1963; 46:758-760.
362. Buchwald H. Postoperative use of percutaneous tracheal stimulation. Surgery 1962; 51:760-763.
363. Buchwald H. The surgical treatment of coronary heart disease: A review and critique of the
literature. Dis of the Chest 1959; 36:189-198.
364. Van Arsdel PP, Middleton E Jr, Sherman WB, Buchwald H. A quantitative study on the in vitro
release of histamine from leukocytes of atopic persons. J of Allergy 1958; 29:429-437.
Electronic Publications
1. Live Broadcasts presented by Synovis:
Buchwald H (moderator), Hutcher N, Shikora SA, Lindstrom W Jr: Panel discussion – “Access to
Surgical Intervention for Metabolic Syndrome and Other Diseases”, 2008
http://www.orlive.com/or-live-participant/buchwald
2. Henry Stewart Online Seminars: “Bariatric/Obesity Surgery”, 2007
http://hstalks.com/main/browse_talk_info.php?talk_id=574&series_id=32&c=252
3. Buchwald H and Ikramuddin S. Bariatric Surgery Primer CD-ROM, the American College of
Surgeons. Released April 2004.
Books
1. Buchwald H. Let Me Tell You A Story: A Memoir: Volume III. Cabin Summer Editions, Scheduled
2020.
2. Buchwald, H. A surgical renaissance in the Heartland: a memoir of the Wangensteen era. Minneapolis,
MN: University of Minnesota Press, 2020.
3. Buchwald H. A New Way: The Wangensteen Era. University of Minnesota Press, 2019.
4. Buchwald H. Let Me Tell You A Story: A Memoir: Volume II. Cabin Summer Editions, 2017.
5. Buchwald H. Let Me Tell You A Story: A Memoir: Volume I. Cabin Summer Editions, 2015.
6. Buchwald H. Buchwald’s Atlas of Metabolic & Bariatric Surgical Techniques and Procedures.
Elsevier, New York, 2011.
7. Buchwald H. Supplement to Surgery for Obesity and Related Diseases (SOARD), vol. 4, May/June
2008, Guest Editor. Papers presented at the International Symposium on Gastric Banding,
September 5, 2007 at the annual meeting of the International Federation for the Surgery of Obesity
and Metabolic Disorders (IFSO), in Porto, Portugal.
8. Buchwald H., W Gillison, Editors. Pioneers in Surgical Gastroenterology, tfm Publishing Limited,
Shrewsbury, UK, 2007.

CURRICULUM VITAE
30
9. Buchwald H, GSW Cowan Jr and WJ Pories, Editors. Textbook: Surgical Management of Obesity;
Elsevier Science, Philadelphia, PA, 2007.
10. Buchwald H and Ikramuddin S. Laparoscopic Adjustable Gastric Banding in Bariatric Surgery: An
Overview of the LAP-BAND, Guest Editors. Amer J Surg Suppl, vol 184, December 2002.
11. Buchwald H. American College of Surgeons Surgical Research and Education Symposium 1992,
Editor
12. Buchwald H, Rohde TD. Implantable Pumps. ASAIO Primers in Artificial Organs, Number 2; J.B.
Lippincott Co., Publ., Philadelphia, 1987.
13. Buchwald H. The Surgical Clinics of North America: Symposium on Morbid Obesity, Guest Editor.
W. B. Saunders Co., Publ., 1979.
14. Buchwald H. Archives of Surgery: Symposium on Serum Lipids and Atherosclerosis. Guest Editor.
Arch. Surg. 113:18-83, 1978.
15. Buchwald H, Varco RL. Metabolic Surgery, Editors, Grune and Stratton, Publ, New York, 1978.
Chapters in Books
1. Buchwald H. Approved for Publication - Definition and History of Metabolic Surgery in
Management of Metabolic Bariatric Complications (scheduled for publication in October 2020).
2. Buchwald H. Approved for Publication - History of Metabolic/Bariatric Surgery and Evolution of
Evidence for the Quality in Obesity Treatment textbook edited by Dr. John Morton.
3. Buchwald H. Approved for Publication - The Benefits of Metabolic/Bariatric Surgery on
Diabetes Mellitus in Transplantation, Bioengineering, and Regeneration of the Endocrine
Pancreas.
4. Buchwald H. Approved for Publication - Foreword to Clinics in Bariatric and Metabolic Surgery.
5. Buchwald H. Metabolic surgery. In: Lucchese M, Scopinaro N, eds. Minimally Invasive Bariatric
and Metabolic Surgery. New York: Springer Int’l Publ, 2015: 69-79.
6. Buchwald H, Rohde TD (January 2013). Implantable Pumps and Ports. In: eLS 2013. John
Wiley& Sons Ltd: Chichester. http://www.els.net/ [DOI:
10.1002/9780470015902.a0002301.pub3].
7. Buchwald H. Metabolic Surgery and Intestinal Bypass for Hyperlipidemia. In: Fischer JE, ed.
Fischer’s Mastery of Surgery, 6th
Edition. Philadelphia: Lippincott Williams & Wilkins,
2012:1556-63.
8. Buchwald H. Metabolic/Bariatric Surgery Therapy for the Metabolic Syndrome. In: Byrne CD,
Wild SH, eds. The Metabolic Syndrome, 2nd
Edition. Chichester, England: John Wiley & Sons,
Ltd. 2011:347-56.
9. Buchwald H. Search for ethics and professional in the surgical profession: a historical, literary,
and philosophical perspective. In: Frezza EE, ed. Professionalism & Ethics in a Surgical
Practice; Woodbury, CT: Ciné- Med, Inc 2008: 25-33.
10. Buchwald H, Rohde TD. (April 2008) Implantable Pumps and Ports. In: eLS. John Wiley & Sons
Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0002301.pub2].

CURRICULUM VITAE
31
11. Buchwald H. Surgical treatment and comorbidities. In: Bray GA, Bouchard C, Eds. Handbook of
Obesity: Clinical Applications, 3rd Edition. New York: Informa Healthcare 2008: 485-502.
12. Menchaca HJ, Michalek VN, Rohde TD, Buchwald H. Bariatric surgery may enhance energy-
efficient aerobic metabolism. Surg Obes Relat Dis 2008; 4(3):306-307.
13. Buchwald H. Intestinal bypass for hypercholesterolemia. In: Mastery of Surgery, 5th
Edition;
Eds:J.E. Fischer, K.I. Bland; Lippincott Williams & Wilkins, Philadelphia, PA; Chapter 124 (web
only), 2007.
14. Buchwald H. Obesity comorbidities. In: Buchwald H., Pories W, Cowan Jr GM, eds. Surgical
Management of Obesity. Philadelphia: Elsevier, 2007: 37-44.
15. Buchwald H, Buchwald JN. Evolution of bariatric procedures and selection algorithm. In:
Buchwald H., Pories W, Cowan Jr GM, eds. Surgical Management of Obesity. Philadelphia:
Elsevier, 2007: 147-157.
16. Buchwald H. The arrival of bariatric surgery. In: Buchwald H, Gillison W, eds. Pioneers in
Surgical Gastroenterology. Shrewsbury, UK: tfm Publishing Limited, 2007: 65-87.
17. Buchwald H. Intestinal bypass for hypercholesterolemia. In: Mastery of Surgery; Ed: R.J. Baker,
J.E. Fischer; Lippincott Williams & Wilkins., Philadelphia, PA; 4th
Edition, 2001, pp 1417-1424.
18. Buchwald H, Rohde RD. Implantable pumps and ports. In: Encyclopedia of Life Sciences (On-
Line Publication – www.els.net); Ed: S Robertson; Nature Publishing Group, 2001.
19. Buchwald H. Program on the Surgical Control of the Hyperlipidemias (POSCH) Trial: A pivotal
25- year study. In: Cholesterol-Lowering Therapy; Ed: SM Grundy; Marcel Dekker, Inc., New
York; 1999, pp 117-149.
20. Buchwald H. Intestinal bypass for hypercholesterolemia. In: Mastery of Surgery; Ed: L.M. Nyhus,
R.J. Baker, J.E. Fischer; Little, Brown & Co., Boston, MA; 3rd
Edition, 1997, pp 1358-1365.
21. Buchwald H, Campos CT. Reoperations following surgery for morbid obesity. In: Reoperative
General Surgery; Eds: DG McQuarrie, EW Humphrey; Mosby - Year Book Inc., St. Louis, 2nd
edition, pp 289-311, 1997.
22. Buchwald H, Campos CT. Pathophysiological basis for lipid intervention trials. In: Lipid-
Lowering Therapy and Progression of Coronary Atherosclerosis; Eds: AVG Bruschke, JHC
Reiber, KI Lie, HJJ Wellens; Kluwer Academic Publishers, Hingham, MA, pp 17-28, 1996.
23. Buchwald H. Tratamiento de la hipercolesteromia. In: Endocrinologia: Controversias médico-
quirúrgicas; Eds: MF Herrera, EL Garber, JR Rodrigo, MC Fernández; McGraw-Hill
Interamericana, Mexico, pp 342-3, 1996.
24. Campos CT, Buchwald H, Bourdages H. Gastric surgery for obesity. In: Digestive Tract
Surgery: A Text & Atlas. Eds: RH Bell, LF Rikkers, MW Mulholland; JB Lippincott Co,
Philadelphia, PA, 281-294, 1995.
25. Campos CT, Buchwald H, and the POSCH Group. The POSCH trial - importance of cholesterol
lowerng in reducing coronary heart disease progression. In. Grotto AM, Lenfant C, Paoletti R,
Zanchetti A, eds. Multiple Risk Factors in Cardiovascular Disease. Dordrecht: Kluwer Academic
Publishers pp 259-266, 1995.
26. Buchwald H, Campos CT, Boen JR, Nyugen P, Williams SE, for the POSCH Group. The POSCH

CURRICULUM VITAE
32
trial: 13-year follow-up and disease-free interval analysis. In: Atherosclerosis X. Eds: FP
Woodford, J Davignon, A Sniderman. Elsevier Science B.V., pp 1048-1052, 1995.
27. Buchwald H, Campos CT. Indications for and technique of partial ileal bypass. In: Surgery of the
Esophagus, Stomach and Small Intestine; Eds: LM Nyhus, C Wastell, PE Donahue; Little Brown
& Co, Boston, MA, pp 948-957, 1995.
28. Campos CT, Buchwald H. Partial ileal bypass - Results of the Program on the Surgical Control of
the Hyperlipidemias (POSCH). In: Proceedings of the XI International Symposim on Drugs
Affecting Lipid Metabolism. Eds: AM Gotto and R Paoletti; Kluwer Academic Publ, Dordrecht,
The Netherlands, 1993.
29. Buchwald H. NIH Funding: Contracts, Grants, and Cooperative Agreements. American College
of Surgeons Surgical Research and Education Symposium, 1992.
30. Buchwald H, Fitch LL, Matts JP, Long JM, Campos CT, and the POSCH Group. POSCH
Update: clinical and arteriographic results. Proceedings of the 9th
Int'l Symposium on
Atherosclerosis. Eds: O Stein, S Eisenberg, Y Stein; R&L Creative Communications, Ltd; Tel
Aviv, Israel; pp 445-448, 1992.
31. Buchwald H, Campos CT, Fitch LL. Partial ileal bypass for hypercholesterolemia. In: Surgery of
the Stomach, Duodenum, and Small Intestine, 2nd
Edition. Eds: Scott HW Jr, Sawyers JL;
Blackwell Scientific Publ, Boston, MA, pp 903-924, 1992.
32. Buchwald H. Intestinal bypass for hypercholesterolemia. In: Mastery of Surgery; Ed: L.M. Nyhus;
Little, Brown & Co., Boston, MA; 2nd
Edition, pp 1169-1174, 1992.
33. Campos CT, Buchwald H. Remedial operations in obesity surgery. In: Reoperative General
Surgery; eds DG McQuarrie, EW Humphrey; Mosby - Year Book Inc., St. Louis, pp 270-291,
1992.
34. Buchwald H, Campos CT, and the POSCH Group. Preliminary results of the Program on the
Surgical Control of the Hyperlipidemias (POSCH). Proceedings of the 7th
Int'l Atherosclerosis
and Cardiovascular Disease Meeting. Eds: GC Descovich, A Gaddi, GL Magri, S Lenzi; Kluwer
Academic Publishers, Dordrecht, The Netherlands, pp 379-382, 1990.
35. Buchwald H, Kernstine KH, Rohde TD. The role of the implantable pump in chemotherapy for
liver neoplasms. In: Progress in Hepatic, Biliary, and Pancreatic Surgery; Eds: JS Najarian, JP
Delaney; Yearbook Med Publ, Chicago, IL, pp 91-97, 1990.
36. Buchwald H, Campos CT. Partial ileal bypass for control of hyperlipidemia and atherosclerosis.
Chapter in Gibbon's Surgery of the Chest, Fifth Edition; Eds: D.C. Sabiston, Jr. and F.C. Spencer;
W.B. Saunders Company, Philadelphia, PA, 1990, pp 1799-1820.
37. Kernstine KH, Rohde TD, Kryjeski SR, Ekerholm PA, Buchwald H. The economic impact of
implantable insulin devices on health care systems. In: Update in Drug Delivery Systems; Eds:
WD Ensminger, JL Selam; Mt Kisco, NY, Futura Publ Co, 1989, pp 125-140.
38. Kernstine KH, Knatterud G, Fisher M, Rohde TD, Buchwald H. Implantable insulin pumps in
humans: ISGIID Registry report. In: Update in Drug Delivery Systems; Eds: WD Ensminger, JL
Selam; Mt Kisco, NY, Futura Publ Co, 1989, pp 75-82.
39. Campos CT, Matts JP, Fitch LL, Speech JC, Long JM, Buchwald H. Modification of plasma
lipoproteins following partial ileal bypass: Five-year results of the Program of the Surgical Control

CURRICULUM VITAE
33
of the Hyperlipidemias. In: Atherosclerosis VIII, Proceedings of the 8th International Symposium
on Atherosclerosis, Rome, 9-13, October 1988; Eds. G. Crepaldi et al, Elsevier Science Publishers
B.V., Amsterdam, 1989, pp 769-774.
40. Rohde TD, Buchwald H, Blacksear PJ. Implantable infusion pumps. In: Drug delivery devices:
fundamentals and applications, ed P Tyle; Marcel Dekker Inc, New York, 1988, 235-260.
41. Buchwald H, Campos CT, Fitch LL. Intervention trials and community management of the
hyperlipidemias. In: Progress in Vascular Surgery, eds JS Najarian and JP Delaney; Year Book
Med Publ, Inc., Chicago, IL, 1988, pp 23-37.
42. Buchwald H, Fitch LL, Rucker RD Jr, Varco RL. Management of morbid obesity and
hyperlipidemia. In: Hardy's Textbook of Surgery; 2nd
Edition. Ed. James D. Hardy; J.B. Lippincott
Co. Publ, New York, 1988, 744-760.
43. Buchwald H, Fitch LL, Varco RL. Partial ileal bypass for hyperlipidemia. In: Surgery of the
Stomach, Duodenum, and Small Intestine. Eds: Scott HW Jr, Sawyers JL; Blackwell Scientific
Publ, Boston, MA, 1987, pp 953-977.
44. Buchwald H, Rucker RD Jr: Rise and fall of jejunoileal bypass. In: Surgery of the Small Intestine.
Eds: RL Nelson, LM Nyhus; Appleton-Century Crofts, 1987, pp 529-541.
45. Buchwald H, Fitch L, Varco RL: Partial ileal bypass; hypercholesterolemia; atherosclerosis. In:
Surgery of the Small Intestine. Eds: RL Nelson, LM Nyhus; Appleton Century Crofts, 1987, pp
547- 571.
46. Buchwald H: Surgical modification of the host response to nutrients. In: Nutritional Diseases:
Research Directions in Comparative Pathobiology. Eds: Scarpelli DG, Migaki G. Alan R. Liss
Inc., New York, pg 525-543, 1986.
47. Chute EP, Rohde TD, Goldenberg FJ, Hitchcock CR, Kernstine KH, Rupp WM, Buchwald H.
Forty-one insulin pump implantations with low morbidity and no mortality. In: Nose Y,
Kjellstrand C, Ivanovich P, eds. Progress in Artificial Organs. Cleveland: ISAO Press 1986: 658-
661.
48. Buchwald H, Chute EP, Kernstine KH, Rupp WM, Dorman FD, Goldenberg FJ, Rohde TD.
Implantable insulin infusion devices. In: Nose Y, Kjellstrand C, Ivanovich P, eds. Progress in
Artificial Organs. Cleveland: ISAO Press 1986: 640-646.
49. Buchwald H: Partial ileal bypass: A surgical approach to cholesterol lowering. In: Perspectives in
Lipid Disorders. McGraw-Hill Publ Co, New York, vol 3, issue 4, 1986.
50. Buchwald H, Chute EP, RUPP WM, Goldenberg FJ, Rohde TD: The development and clinical use
of the implantable infusion pump. In: Advances in Hepatic, Biliary & Pancreatic Surgery,
Yearbook Med Publ, Chicago, IL, p501-508, 1985.
51. Buchwald H, Rohde TD: Implantable infusion pumps. In: Advances in Surgery; Ed: GT Shires;
Year Book Med Publ, Chicago, vol 18, pp 177-221, 1984.
52. Buchwald H: Intestinal bypass for hypercholesterolemia. In: Mastery of Surgery; Ed: L.M. Nyhus;
Little, Brown and Company, Publ.; Vol. II, p 901-907, 1984.
53. Buchwald H, Rupp WM, Barbosa JJ, Rohde TD, Goldenberg FJ, Bordewich PH, Hitchock C,
Wigness BD, Blackshear PJ: Insulin pump treatment of Type II diabetes: Indications and results.
In: Diabetes Treatment with Implantable Insulin Infusion Systems. Eds. K Irsigler, H Kritz, R

CURRICULUM VITAE
34
Lovett; Urban and Schwarzenberg, Vienna, p64-70, 1983.
54. Buchwald H, Rucker RD Jr: A history of surgery for morbid obesity. In: Advances of
Gastrointestinal Surgery; Eds. JS Najarian, JP Delaney; Year Book Med. Publ., Chicago, p 235-
249, 1983.
55. Buchwald H, Schwartz RA: Hyperlipidemia. In: Nutrition and Metabolism in the Surgical Patient;
Ed. John R. Kirkpatrick, Futura Publ Co, Inc., New York, p503-525, 1983.
56. Blackshear PJ, Rohde TD, Rupp WM, Buchwald H: A totally implantable, constant rate insulin
infusion device: preliminary studies in Type II diabetic subjects. In: Alberti KGMM, Albisser AM,
Burnetti P Eds: Artificial Systems for Insulin Delivery. New York: Raven Press, pl31-139, 1983.
57. Buchwald H, Moore RB, Rucker RD Jr, Varco RL: Metabolic surgery; Management of morbid
obesity and hyperlipidemia. Chapter in Hardy's Textbook of Surgery, Ed: James D. Hardy, p722-
37, 1983.
58. Buchwald H, Moore RB, Varco RL: Partial ileal bypass for control of hyperlipidemia and
atherosclerosis. Chapter in Gibbon's Surgery of the Chest, Fourth Edition; Eds: D.C. Sabiston, Jr.,
F.C. Spencer; W. B. Saunders Co., Philadelphia, Publ., pl515-34, 1983.
59. Buchwald H, Fitch LL, Moore RB: Atherosclerosis-Hyperlipidemia Trials: past, present, and
future. Chapter in Advances in Vascular Surgery; Eds: John S. Najarian and John P. Delaney;
Yearbook Medical Publishers, Chicago, 1983, pp65-79.
60. Buchwald H, Varco RL: Management of hypercholesterolemia by partial ileal bypass. Chapter in
Nutrition and Heart Disease; Ed: H.K. Naito; SP Medical c Scientific Books, Div. of Spectrum
Publications, Publ., New York; 1982, p265.
61. Buchwald H, Moore RB, Varco RL: Surgery in the therapy of atherosclerosis: Partial ileal bypass.
Chapter in Atherosclerosis: Clinical Evaluation and Therapy; MTP Press Limited, International
Medical Publ.; p473-484, 1982.
62. Buchwald H, Rucker RD Jr, Moore RB, Amplatz K, Varco RL: Regression of atherosclerosis by
surgical cholesterol reduction. Chapter in Lipoproteins and Coronary Atherosclerosis; Eds: G.
Noseda, C. Fragiacomo, R. Fumagalli, R. Paoletti; Elsevier Biomedical Press; 1982, p417-424.
63. Buchwald H, Rucker RD Jr, Varco RL, Horstmann JP: Liver changes in obesity and following
obesity operation. Chapter in Hepatic, Biliary and Pancreatic Surgery; Eds: J.S. Najarian, J.P.
Delaney; Symposia Specialists, Inc., Yearbook Medical Publ., Chicago; 1980, p433-440.
64. Dunn D, Buchwald H: Gastrointestinal anastomoses: Facts and fiction. Chapter in Gastrointestinal
Surgery; Eds: J.S. Najarian, J.P. Delaney; Symposia Specialists, Miami, Publ.; 1979, p681-700.
65. Schneider PD, Buchwald H: Current status of jejunoileal bypass for the treatment of morbid
obesity. Gastrointestinal Surgery; Eds: J.S. Najarian, J.P. Delaney; Symposia Specialists, Miami,
Publ.; 1979, p461-471.
66. Buchwald H, Varco RL: The results of partial ileal bypass for hypercholesterolemia. Vascular
Surgery; Eds: J.S. Najarian, J.P. Delaney; Symposia Specialist, Inc., Miami, Publ; 1978, 21-31.
67. Buchwald H, Amplatz K, Knight L, Guzman IJ, Varco RL. Arteriography changes after partial
ileal bypass. Proceedings of Symposium on the State of Prevention and Therapy in Human
Atherosclerosis and in Animal Models, Munster, Westdeutscher Verlag, West Germany, 1978;
469-482.

CV

Recommended

Recommended

More Related Content

Similar to CV

Similar to CV (20)

More from DanielBerkowitz11

More from DanielBerkowitz11 (6)

Recently uploaded

Recently uploaded (20)

CV